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Viruses hijack the host machinery for their proliferation and spread. This 
includes the host cytoskeleton. Alphaherpesvirus viral capsids are assembled 
in the nucleus of an infected cell and then require to be trafficked to various 
host compartments for tegumentation, secondary envelopment and egress. 
Microtubules are important for long-distance transport of viral particles inside 
host cells. Marek's Disease Virus (MDV) is an Alphaherpesvirus and is the 
causative agent of a lymphoproliferative disease called Marek's Disease (MD) 
in poultry. Here, we demonstrate that both microtubules and actin are required 
for cell-to-cell spread of MDV in culture. We show that MDV infection induces 
cell shape changes and these changes depend on dynamic microtubules. 
Using live cell super-resolution microscopy, we show that the majority of MDV 
viral particles are associated with microtubules and that MDV particles are 
transported along microtubules. Cytoplasmic dynein and KIF13B molecular 
motors have been identified to contribute to the directional transport of MDV 
viral particles along microtubules. Thus, the findings from this study identify 
new components of the host machinery required for MDV biology and open 
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Chapter 1: Introduction  
 
1.1: Cytoskeleton: Microtubules and Filamentous Actin 
 
The eukaryotic cytoskeleton, comprised of actin filaments, intermediate 
filaments, microtubules and other structural molecules, performs a broad 
range of complex functions. These include: cell motility, determination of cell 
shape, internal structure, vesicle trafficking and chromosome transport during 
mitosis (Ayscough and Drubin, 1996, Barkalow and Hartwig, 1995, Goodson 
et al., 1997, Kuriyama and Nislow, 1992, McLean and Lane, 1995). The 
individual components of the cytoskeleton are interlinked to form a dynamic 
network to access all parts of the cytoplasm and the plasma membrane (Cowin 
and Burke, 1996, Svitkina et al., 1996). This makes the host cytoskeleton an 
essential target for exploitation during a viral infection. 
 
1.1.1: Microtubules  
Microtubules (MT) are cytoplasmic hollow tubular structures 25 nm in diameter 
(Mandelkow and Mandelkow, 1989). They are comprised of polymers of 
heterodimeric alpha (α) and beta (β) tubulin. Tubulin is arranged in a manner 
where the α-tubulin and β-tubulin are exposed at the plus and minus ends 
respectively (Fig 1.1A-B). Nucleation of microtubules is dependent on γ- 
tubulin ring complexes which have a 13-fold symmetry that acts as a template 
for α/ β-tubulin dimers to bind and extend (Kollman et al., 2010). Usually a 
microtubule originating centre (MTOC) is located in the perinuclear region of 
the cell (de Forges et al., 2012). It contains a gamma tubulin ring complex (γ-
TuRC) and anchors the minus end of microtubules and thereby stabilizes 
them. The plus end of a microtubule is much more dynamic compared to the 
minus end and extends towards the cell periphery.  
 
The plus end of a microtubule structurally switches between polymerisation 
and depolymerisation, undergoing catastrophes. A catastrophe is a rapid 
switch from growth to microtubule shrinkage. This dynamic instability of 
microtubules is driven by GTP/GDP hydrolysis (Howard and Hyman, 2009). 
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GTP is associated with β-tubulin subunits at the plus end of the microtubule 
this forms a GTP cap, and if new GTP subunits are quickly incorporated, then 
hydrolysis of GTP to GDP does not occur fast enough to lose the stabilizing 
cap. However, if new subunits are not incorporated faster than GTP hydrolysis, 
possibly due to low local tubulin subunit concentrations, then the cap is lost.  
Exposed GDP-tubulin will trigger microtubule depolymerisation (Mitchison and 
Kirschner, 1984, Weisenberg, 1972, Weisenberg et al., 1976) (Fig 1.1B). This 
inherent instability of the microtubule cytoskeleton makes it highly dynamic, 
enabling rapid structural changes to the microtubule network in response to 
extracellular stimuli.  
 
Microtubule-associated proteins (MAPs) are responsible for the maintenance 
and regulation of the microtubule network. Microtubule dynamics change 
drastically during the life time of the cell. This is due to MAPs that promote 
growth and disassembly. XMAP215 is a microtubule polymerase that binds to 
the plus end and recruits tubulin dimers to increase the rate of growing 
microtubules (Al-Bassam et al., 2012, Brouhard et al., 2008). End binding (EB) 
proteins are another family of proteins that and promote microtubule 
polymerisation (Komarova et al., 2009, Zanic et al., 2013). Kinesin-13 family 
members like mitotic centromere-associated kinesin (MCAK) promote 
microtubule disassembly by removing tubulin subunits from the microtubule 
plus end (Asenjo et al., 2013, Burns et al., 2014, Desai et al., 1999, Hunter et 
al., 2003, Moores et al., 2002). Kinesin-8 family members have also been 
suggested to remove tubulin subunits from the growing plus end of a 
microtubule (Gardner et al., 2011). Kinesin-4 family members have been 
suggested to inhibit microtubule growth and supress catastrophes (Bieling et 
al., 2010, van der Vaart et al., 2013). This leads to the formation of 
microtubules of particular length which are important for microtubules in the 
spindle and cell cortex. Cytoplasmic linker protein (CLIP) –associated proteins 
(CLASPs) have also shown catastrophe inhibiting and rescue promoting 
activity. They have been shown to bind to the microtubule lattice and recruit 
tubulin dimers (Al-Bassam et al., 2010). Tau, a microtubule lattice binding 
protein has also been shown to induce microtubule stability (Kadavath et al., 
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2015). These proteins and many others can tightly control and regulate 
microtubule dynamics and ensure its proper function. 
 
Post-translational modifications (PTMs) of tubulin have been shown to control 
and regulate the microtubule network. These include; polyglutamylation, 
polyglycylation, acetylation and detyrosination (Arce et al., 1975, Edde et al., 
1990, Hallak et al., 1977, L'Hernault and Rosenbaum, 1985, Redeker et al., 
1994). The majority of PTMs occur on tubulin subunits after polymerization, 
apart from phosphorylation of serine residue S172 of β-tubulin by the Cdk1 
kinase. This phosphorylation inhibits subunits incorporating into growing 
microtubules, thereby controlling rate of microtubule growth (Fourest-Lieuvin 
et al., 2006). Acetylation of the ε-amino group of residue K40 of α-tubulin is 
highly conserved and occurs in the microtubule lumen. Acetylation is a marker 
of stable microtubules (L'Hernault and Rosenbaum, 1985, LeDizet and 
Piperno, 1987, Nogales et al., 1998). Tubulin detyrosination is the removal of 
the C-terminal tyrosine residue on α-tubulin and occurs after tubulin subunits 
are incorporated into the microtubule lattice. This PTM is thought to limit the 
amount of α-tubulin that undergoes recycling and has been shown to be 
involved in: microtubule and intermediate filament interactions, cell 
differentiation and polarization of cells (Hallak et al., 1977, Kreitzer et al., 1999, 
Kumar and Flavin, 1981, Quinones et al., 2011, Zink et al., 2012). In migrating 
cells, a subset of microtubules that are oriented towards the leading edge are 
much more stable and enriched with acetylation and detyrosination (Palazzo 
et al., 2004). Glutamylation and glycylation are PTMs that form peptide chains 
on the C-terminal tail of α-tubulin. The chains branch with multiple glutamic 
acids from the C-terminal tail. This PTM is abundant on microtubules of 
centrioles, axons and basal bodies, and on some cytoplasmic and spindle 
microtubules (Bobinnec et al., 1998, Bre et al., 1994, Edde et al., 1990, 
Redeker et al., 1994, Wolff et al., 1992). The distribution of different PTMs at 
different cellular sites and during different stages of the cell cycle indicates 
their importance in facilitating the multiple roles of the microtubule network.  
 
Detyrosination has been suggested to play a role in motor protein function. 
The kinesin-13 family of motors has been shown to preferentially bind to the 
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tyrosinated plus end of microtubules suggesting detyrosination may protect 
against kinesin-13 mediated depolymerisation (Ghosh-Roy et al., 2012, Peris 
et al., 2009). Detyrosination has also been suggested to increase affinity of 
kinesin-1 binding to microtubules (Liao and Gundersen, 1998). Kinesin-1 has 
also been shown to preferentially bind to detyrosinated microtubules and have 
a slower rate of movement in neurons (Dunn et al., 2008). Acetylation of 
microtubules have also been suggested to increase kinesin-based transport, 
especially kinesin-1 (Reed et al., 2006). From these studies it is clear that 
PTMs have a distinct role to play when determining where and when kinesins 









Figure 1.1: The cellular cytoskeleton 
(A) Visualization of the cytoskeleton in cells. Images show microtubules, actin and the nucleus 
from the same fibroblast cell. Scale bar is 10 µm.  (B) Schematic representation of 
microtubules and dynamic instability. The cycle of tubulin polymerization and disassembly is 
powered by hydrolysis of the GTP bound to β-tubulin, which enables microtubules to switch 
between catastrophes and rescues. GTP-bound tubulin dimers are incorporated into 
polymerizing microtubules. GTP hydrolysis occurs, with a delay, after a GTP-tubulin dimer 
incorporates into the growing microtubule plus end. Growing microtubule ends maintain a GTP 
cap, the loss of which leads to a catastrophe and depolymerization. (C) Schematic 
representation of F-actin polymerization. G-actin monomers are lost at the pointed end. New 





The polarity of microtubules is essential to the function of microtubules for 
transport and cargo positioning. Cargo includes but is not limited to organelles, 
vesicles and chromosomes (Tanenbaum and Medema, 2010). Transport of 
cargo is dependent on the microtubule-associated molecular motors dynein 
and kinesin. These molecular motors hydrolyse ATP to ‘walk' on microtubules 
to transport cargo. Cytoplasmic dynein is a minus end directed transporter and 
most kinesins are plus end-directed motors (Hepperla et al., 2014). These 
molecular motors allow the movement of cargo to and from the nucleus (Allan, 
2011, Hirokawa et al., 2009) as well as vesicles from the endoplasmic 
reticulum (ER) to the Trans-Golgi-Network (TGN) and then to the plasma 
membrane for protein secretion (Aplin et al., 1992).   
 
The dense environment in the cytoplasm is a major barrier to the free 
movement of large structures like viral particles. Microtubule dependent 
transport of viral particles has been shown to be essential to many different 
viruses like pox, herpes and retro viruses (Martinez et al., 2008, Mettenleiter 
et al., 2009) 
 
1.1.2: Filamentous Actin 
Filamentous actin is crucial to the maintenance of the cell shape, muscle 
contraction, formation of cell protrusions and constrictive fibres (Pollard and 
Cooper, 2009). Actin is found in two distinct states in the cell: the globular 
monomeric G-actin and the filamentous F-actin. F-actin filaments are polarised 
like microtubules. ATP-bound actin monomers are incorporated into the 
barbed end, and ADP bound actin is lost at the pointed end of the filament (Fig 
1.1C) (Khaitlina, 2014, Woodrum et al., 1975). G-actin is abundant in cells, 
and F-actin is self-assembling, however, the initial nucleation step (formation 
of F-actin from G-actin) is rate limiting.  
 
Several proteins control nucleation and dynamics of actin. Formins are dimeric 
membrane-bound proteins that interact with F-actin. These proteins increase 
the rate of barbed end elongation and inhibit the role of capping protein, which 
in turn inhibits elongation. Barbed end elongation allows the generation of 
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forces required to push the plasma membrane for filopodia (actin rich 
membrane protrusions) formation (Yang and Svitkina, 2011).  The Arp2/3 
complex is a heptameric protein complex made from Arp2, Arp3 and five other 
additional subunits. This complex initiates the formation of a branched actin 
network for endocytosis and cell motility (Machesky et al., 1994, Mullins et al., 
1998, Pollard and Borisy, 2003). The Arp2/3 complex typically requires 
activation from nucleation-promoting factors. Wiskott-Aldrich Syndrome 
protein (WASP) or WASP-family verprolin-homologous protein (WAVE) 
families of proteins are examples of these (Pollard and Beltzner, 2002).  
 
Myosin is a superfamily of actin-dependent molecular motors similar to 
kinesins and dynein motors that are microtubule dependent. The motors have 
a semi-conserved catalytic N-terminal head domain that contains both actin 
and ATP binding sites (Masters et al., 2017). Myosins are involved in multiple 
cellular processes such as muscle contraction, actin stress fibre contraction, 
contraction of the actin/myosin ring during cytokinesis and transport of cellular 
cargo along F-actin. The majority of myosin motors move towards the barbed 
end of F-actin, with myosin VI as an exception that moves towards the pointed 
end (Hartman and Spudich, 2012, Masters et al., 2017, Thompson and 
Langford, 2002). 
 
Viral infection has been shown to exploit the normal functions of the cell, this 
also includes the actin cytoskeleton. Actin reorganisation has been shown 
during many viral infections, including Respiratory syncytial virus (RSV), 
SV40, adenoviruses and herpesviruses (Bachvaroff et al., 1980, Bellett et al., 








1.2: Alphaherpesviruses  
The family Herpesviridae that is in the order of Herpesvirales contains over 
one hundred different viruses of which 8 have tropism for humans. This family 
is divided into a further 3 sub families called; Alpha-, Beta- and 
Gammaherpesvirinae based on genetic sequences, biological characteristics 
and the cell types in which viral latency is established (Davison et al., 2009).  
 
The Alphaherpesvirinae or Alphaherpesviruses family contains many clinically 
and economically important viruses like Herpes Simplex Virus -1/2 (HSV 1/2), 
Pseudorabies virus (PRV), Varicella-Zoster Virus (VZV) and Marek’s Disease 
Virus (MDV) (Fig 1.2). The members of this sub family are generally 
associated with establishing latency in neurons. Clinically, HSV manifests in 
individuals as ocular, orolabial or genital lesions. It is also implicated in 
neonatal encephalitis in immunocompromised or immunonaive patients (Al-
Dujaili et al., 2011). VZV is the causative agent of human chicken pox and 
reactivation later in life results in singles (Pergam et al., 2009). PRV infection 
is associated with high mortality rates in young swine (Muller et al., 2011). 
MDV is associated with strong immunosuppression, tumours, and neurological 
disorders in poultry and is a great economic burden to the poultry industry 
costing £1 billion worldwide (Nair, 2005). MDV was originally classified as a 
Gammaherpesvirus due to its lymphotropism, however it was changed to a 
member of the Alphaherpesvirinae due to it more closely being related these 
neurotropic viruses at the nucleotide level as the MDV genome structure more 
closely resembles those of the Alphaherpesvirinae family members 
(Buckmaster et al., 1988). The life cycle and disease progression of MDV is 
very similar to VZV, even though sites of latency differ.  
 
While there are many differences between the viruses of the 
Alphaherpesvirinae subfamily, there is sufficient homology to study 
homologous proteins in order to further develop understanding of viral 
trafficking and replication during the Alphaherpesvirus life cycle. For all 
Alphaherpesviruses viral replication occurs in the nucleus (Hay and 
Ruyechan, 2007). Therefore, transport mechanisms are required for viral 
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nucleocapsids (viral capsid containing dsDNA) to and from the nucleus. It has 
been calculated that it could take up to 200 years of passive diffusion for viral 
capsids to travel 1cm in the cytoplasm due to the crowdedness of proteins in 
the cytoplasm and the size of the nucleocapsids (Sodeik, 2000). Therefore, 
active transport of viral capsids is necessary for efficient Alphaherpesvirus 
infection. Investigating viral transport will also highlight crucial virus-host 
interactions. The discovery of these mechanisms will benefit the 
understanding of the Alphaherpesvirus life cycle and potentially lead to novel 
therapeutic options as previously unknown aspects of the viral life cycle can 
be therapeutically targeted.  
 
Figure 1.2: A direct view of an MDV viral particle 
(A) High-pressure frozen electron micrograph (EM) image of an MDV viral particle. Image 
taken at 40,000 x magnification. Scale bar is 100 nm. (B) Schematic representation of MDV 
viral particle from A. Arrows indicate to various aspects of the MDV viral particle. 
 
1.2.1: Alphaherpesviruses: life-cycle 
Alphaherpesviruses HSV-1 and PRV have been extensively studied to attempt 
to understand the molecular events underlying Alphaherpesvirus entry, 
replication, maturation, assembly and egress.  Infection of host cells is usually 
initiated by a nucleocapsid surrounded by a protein tegument layer and is 
encapsulated in a host-derived viral envelope (mature viral particle) (Fig 1.2). 
Alphaherpesvirus nucleocapsids follow a T=16 icosahedral symmetry with 162 
capsomers. Of the 12 vertices one is occupied by a ring-like dodecameric 
complex termed the portal. This is the channel where dsDNA is packaged and 
released from the viral capsid (Chang et al., 2007, Deng et al., 2007, Johnson 
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and Chiu, 2007, Nellissery et al., 2007). The mature viral particle enters the 
host cell via membrane fusion or by endocytosis (Fig 1.3). Cell entry is 
mediated by viral glycoproteins present on the viral envelope called gB, gC, 
gD, gH and gL (Campadelli-Fiume et al., 2007, Spear, 2004).  The 
nucleocapsid, still containing the inner tegument layer with viral proteins such 
as US3, UL36 and UL37, is then transported along microtubules via tegument 
protein interactions with dynein. The viral particle has lost both the envelope 
and most outer tegument layer during entry into the cytoplasm (Antinone and 
Smith, 2010, Granzow et al., 2005). Once in the perinuclear region, the dsDNA 
genome is passed from the viral capsid portal through a nuclear pore complex. 
Upon entry, replication and transcription of viral genes occurs (Kornfeind and 
Visalli, 2018).  
 
The viral mRNA is synthesized by the host cell RNA-polymerase II with the aid 
of viral factors. Transcription of viral proteins occurs in distinct stages: 
immediate early, early and late. Initial expression of immediate early proteins 
occurs via tegument protein VP16 recruiting Oct-1 and HCFC1 to form a 
complex that activates the transcription of immediate early proteins (Herrera 
and Triezenberg, 2004, Mackem and Roizman, 1982). Immediate early 
proteins then facilitate the expression of early genes that includes UL30, a 
virally encoded DNA polymerase that starts the replication of the viral genome 
(Digard et al., 1993, Skaliter and Lehman, 1994, Stow, 1993, Zuccola et al., 
2000). Late phase protein production is facilitated by the early phase proteins 
and these include the expression of viral structural proteins that form the 
capsid (Newcomb et al., 1996) 
 
For viral capsid assembly viral capsid proteins UL19, the major capsid protein 
forming the capsomer pentons and hexons, UL18 and UL38, the triplex 
proteins residing between and connecting the capsomers, as well as UL26 the 
maturational protease are required (Desai et al., 1998, Gibson, 2008). The 
small capsid protein UL35, which decorates hexon tips has been shown to be 
nonessential to Alphaherpesviruses (Krautwald et al., 2008).  
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Packaged nucleocapsids undergo nuclear egress to leave to nucleus. Several 
models have been suggested as to how nucleocapsids leave the host nucleus. 
The most widely accepted and best evidenced model is the primary 
envelopment-de-envelopment-secondary envelopment process. For this to 
occur nucleocapsids need to approach and contact the inner nuclear 
membrane (INM). This is achieved by intranuclear movement of 
nucleocapsids via actin filaments present in the nucleus during HSV-1 and 
PRV infection (Feierbach et al., 2006, Forest et al., 2005). The nuclear egress 
complex (NEC) is responsible for this (Fuchs et al., 2002). The NEC is made 
up of conserved viral proteins UL31 and UL34 and US3 (Reynolds et al., 
2002). UL34 is anchored to the INM by the C-terminal transmembrane helix 
(Shiba et al., 2000). UL31 is a phosphoprotein that localises to the INM via 
UL34 interactions and localises to nucleocapsids (Chang and Roizman, 1993, 
Funk et al., 2015, Roller et al., 2000). The NEC is required for efficient nuclear 
egress. In the absence of either NEC element viral replication is impaired and 
a vast majority of viral nucleocapsids accumulate in the nucleus (Fuchs et al., 
2002, Roller et al., 2000). The multifunctional viral protein US3 has also been 
shown to be associated with the NEC by phosphorylating UL31 and UL34. 
Phosphorylation of UL31 by US3 has been shown to be important for 
regulating the localisation of both UL31 and UL34 to the INM (Mou et al., 2009, 
Reynolds et al., 2002). Once at the INM, the nucleocapsid then fuses with the 
INM and enters the space between the two nuclear membranes and gains a 
primary, inner nuclear membrane derived envelope. This primary envelope is 
then lost by fusion of the primary envelope with the outer nuclear membrane 
(ONM). This results in the nucleocapsid being translocated into the cytoplasm 
(Mettenleiter, 2002, Mettenleiter, 2004, Mettenleiter et al., 2006, Stackpole, 
1969). 
 
The naked viral capsid is then tegumented, whereby the viral capsid acquires 
viral proteins that form the tegument matrix. The nucleocapsid acquires a 
multitude of tegument proteins at different stages through a protein-protein 
network of interactions. The most abundant tegument proteins are UL47, UL48 
and UL49 which are present at 600-1300 copies per viral particle (Newcomb 
et al., 2012). The viral proteins US3, US9 and UL36 are of particular note here 
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as they have been shown to interact with host molecular motors and viral 
capsids (Antinone and Smith, 2010, Granzow et al., 2005). UL36 has been 
shown to drive the transport of HSV-1 nucleocapsids to sites were further 
tegument proteins can be incorporated in to the existing tegument layer before 
acquiring a secondary envelope (Ivanova et al., 2016, Sandbaumhuter et al., 
2013).  
 
The secondary viral envelope is thought to be derived from the Trans-Golgi 
Network (TGN) or an endosome and there is evidence for both (Granzow et 
al., 2001, Hambleton et al., 2004, Henaff et al., 2012, Hollinshead et al., 2012).  
The evidence for the TGN being the site of final envelopment is from co-
localisation studies that show several envelope proteins co-localising with 
TGN markers (McMillan and Johnson, 2001, Foster et al., 2004c, Crump et 
al., 2004, Beitia Ortiz de Zarate et al., 2004). Additionally, it was shown that 
in-cooperating TGN localisation signals to HSV-1 glycoproteins results in 
correct in-corporation into viral particles (Whiteley et al., 1999) and finally, 
inhibiting the TGN function using brefeldin A, results in a block in HSV-1 
assembly, suggesting HSV-1 envelopment occurs by the TGN membrane 
(Koyama and Uchida, 1994, Cheung et al., 1991). More recently there has 
been emerging evidence to support secondary envelopment originating from 
endosomes rather than the TGN. Electron microscopy studies have shown the 
presence of endocytic tracers in plasma membrane endosome compartments 
that wrap around nucleocapsids, this is the most direct evidence to suggest 
that secondary envelopment occurs from plasma membrane derived endocytic 
tubules (Hollinshead et al., 2012). Additionally, blocking the function of specific 
Rab GTPases like Rab6, Rab43 and Rab1a/b that are associated with 
endosomal transport inhibits HSV-1 assembly (Johns et al., 2014, Zenner et 
al., 2011)  and prevents the in-cooperation of viral glycoproteins into virions 
(Albecka et al., 2016). Taken together these data suggest that the membrane 
used for secondary envelopment is derived from endosomal compartments. 
However, due to the dynamic and fluid nature of the secretory and endocytic 
pathways and their markers it is hard to accurately come to distinct 
conclusions as to the identity of the secondary membrane. Especially when 
the cytopathic effects of Alphaherpesvirus infection during its life cycle are 
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taken in to account, as they are known to perturb membrane trafficking and 
cellular organelle structure (Henaff et al., 2012). What is certain is that 
secondary envelopment membranes are derived from the late secretory 
pathway and or the endosomal pathway components and not from early 
secretory pathway membranes such as the ER, as artificially targeting viral 
envelope proteins to the ER prevents in-cooperation in virions and blocking 
ER-Golgi transport inhibits viral assembly and leads to accumulation of viral 
proteins in the ER (Whiteley et al., 1999, Browne et al., 1996, Zenner et al., 
2011). During secondary envelopment the viral nucleocapsid buds into 
vesicles that contain viral glycoproteins that are presented on the surface of a 
mature viral particle. This process results in the simultaneous packaging of the 
viral particle into the vesicle. There is still much debate on where secondary 
envelopment occurs as Alphaherpesviruses are known to reorganise the host 
cytoskeleton, secretory and endocytic pathways. Therefore, determining the 
origin of the secondary envelopment site becomes anything but 
straightforward (Avitabile et al., 1995, Campadelli et al., 1993).  
 
Tegument proteins are thought to contribute to secondary envelopment by 
forming interactions that bridge the viral capsid and vesicle membrane by 
interacting directly with capsid proteins and with the cytoplasmic tails of viral 
glycoproteins or membrane-associated tegument proteins on the vesicle 
(Crump, 2018). The interactions between the tegument and envelope proteins 
are thought to be co-operative and partially redundant. The redundant nature 
of these interactions was described by single deletion analysis of gB, gD or gE 
that has no effect on attenuation of secondary envelopment. The combined 
deletion of gB and gD or gD and gE results in large amounts of cytoplasmic 
non-enveloped viral capsids (Johnson et al., 2011, Farnsworth et al., 2003). 
Direct interaction between gM and lipid-anchored viral protein UL11, where 
deletion of each protein individually results in minor defects but dual deletion 
results in a profound inhibition of secondary envelopment (Leege et al., 2009).  
 
Besides these interactions, the envelope proteins gK and UL20 form a 
complex that depend upon each other for correct subcellular localisation 
(Foster et al., 2004a). The gK-UL20 complex is essential for efficient 
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secondary envelopment and requires both elements as deletion of either 
element results in significant defects in secondary envelopment (Jayachandra 
et al., 1997, Melancon et al., 2004, Foster et al., 2004b). This complex 
interacts with UL37 viral protein and is important for the subcellular localization 
of gD and gH-gL envelope proteins. These interactions suggest that the gK-
UL20 complex is important for organising the viral envelope proteins and 
mediating their interactions with tegument proteins (Lau and Crump, 2015, 
Jambunathan et al., 2014). Several other tegument proteins have been 
suggested to directly interact with the cytoplasmic domains of envelope 
proteins, these are; UL48 with gH, UL49 with gD, gE and gM, UL11 with gD 
and gE and UL37 with gK (Jambunathan et al., 2014, Han et al., 2011, 
Farnsworth et al., 2007, Maringer et al., 2012, Gross et al., 2003). The 
interaction between these tegument and envelope proteins are sufficient to 
drive secondary envelopment as light particles are formed in the absence of 
capsids. These contain most, but not all of the tegument and envelope proteins 
(Szilágyi and Cunningham, 1991, Rixon et al., 1992). These observations 
support the hypothesis that interactions between envelope proteins and the 
tegument layer occur to ensure correct secondary envelopment of viral 
capsids.  
 
Secondary envelopment membrane scission is thought to be mediated by the 
ESCRT pathway (Calistri et al., 2007, Crump et al., 2007, Kharkwal et al., 
2014, Pawliczek and Crump, 2009a) and a fully mature viral particle is created 
and packaged simultaneously as the virion is contained in the lumen of the 
vesicle. It is not fully understood how Alphaherpesviruses recruit and regulate 
the ESCRT machinery at sites of secondary envelopment. There is evidence 
that UL36 interacts with the ESCRT-I subunit TSG101, however this 
interaction is not essential (Pawliczek and Crump, 2009b, Calistri et al., 2015)  
 
Finally, the fully mature viral particle must be transported to the plasma 
membrane to undergo exocytosis. Very little is known regarding how mature 
viral particles are transported after secondary envelopment in non-neuronal 
cells.  Several Rab proteins have been suggested to traffic with viral tegument 
and glycoproteins during egress (Hogue et al 2014, Miranda-Saksena et al 
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2009).  The gE-gL complex has been established to be important for cell-to-
cell spread of HSV in epithelial cells. Deletion or loss of function of the gE-gL 
complex results in a significant reduction in the spread of infection between 
cells in a monolayer. This is thought to be due to the reduced targeting of viral 
particles to cell junctions (Johnson et al., 2001, Dingwell and Johnson, 1998, 
Dingwell et al., 1994). The cytoplasmic domains of both gE and gL are thought 
to be the source of how HSV-1 targets the cell-to-cell junctions in epithelial 
cells for viral spread (Farnsworth and Johnson, 2006a, McMillan and Johnson, 
2001). Microtubule based molecular motors have also been shown to transport 
HSV-1 and PRV viral capsids particularly in neurons (Daniel et al., 2015, 
Diefenbach et al., 2002, Kramer et al., 2012), this is introduced in greater detail 
later on. To date there are no reports in the literature reporting MDV 
association or transport along microtubules. 
 
Upon the mature viral particle reaching the cell periphery it encounters the 
cortical actin, which is a dense mesh of filamentous actin underlying the 
plasma membrane. This is thought to pose as a barrier to the vesicle carrying 
the mature viral particle. This is a similar problem faced by large cellular 
secretory vesicles, such as melanosomes. Actin based motors such as Myosin 
Va has been shown to reorganise the dense network to allow large secretory 
vesicles through and Myosin Va has been shown to be essential for efficient 
HSV-1 release (Roberts and Baines, 2010), other than this very little is known 
regarding how virus containing vesicles pass though the actin cortex. The final 
stage of egress is the fusion of the vesicle containing the viral particle with the 
plasma membrane. Several Rab proteins like Rab3A, Rab6A, Rab8A and 
Rab11A as well as SNARE protein SNAP-25 have been shown to localise to 
vesicles containing viral particles, but their functional role has not been 
investigated (Hogue et al., 2014b, Miranda-Saksena et al., 2009) . Exactly how 
an Alphaherpesvirus viral particle containing vesicles release their cargo is still 





Figure 1.3: Model of Alphaherpesvirus life-cycle in non-neuronal cells 
(1.) A mature virus binds to the host cell surface mediated by viral glycoproteins. Fusion of the 
membranes delivers the viral capsid and the tegument wrapped around it in to the cytoplasm. 
(2.) Much of the tegument layer uncoats from the nucleocapsid. (3.) Dynein mediated transport 
is facilitated by the inner tegument layer towards the MTOC and nucleus. (4.) Upon entry of 
the viral dsDNA in to the nucleus transcription and replication is initiated in the nucleus. (5/6.) 
Viral DNA is transcribed and translated in a temporal manner. (7.) DNA replication is carried 
out in the nucleus. (8.) The viral capsid is assembled in the nucleus. (9.) Newly replicated viral 
dsDNA is packed in to viral capsids to form a nucleocapsid. (10.) Nucleocapsid leaves the 
nucleus and acquires an inner tegument layer. (11.) Vial nucleocapsid is then transported to 
secondary envelopment site. (12.) Secondary envelopment occurs were viral particle gains a 
viral envelope and is packed in to vesicle at the same time. (13.) Viral particle is then 
transported to the cell cortex. (14.) Viral particle is released to the extracellular environment 
via exocytosis. 
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1.2.2: Alphaherpesvirus interactions with the host microtubule network 
An intact and functioning microtubule network is essential for 
Alphaherpesvirus infection (Mabit et al., 2002, Marozin et al., 2004, Topp et 
al., 1994). It has long been established that Alphaherpesviruses target the host 
microtubule network during their life cycle (Brzozowska et al., 2010, Dienes et 
al., 1987, Kotsakis et al., 2001, Pasdeloup et al., 2013a, Pasdeloup et al., 
2013b). However, only a handful of viral proteins have been identified to 
interact with and remodel the microtubule network directly. Most work carried 
out to identify potential Alphaherpesvirus microtubule regulators was carried 
out in HSV-1 infected cells. 
 
Viral protein US3 from HSV-1 has been shown to phosphorylate a kinase in 
NHDF cells and inactivate it. This then leads to microtubule stabilisation by 
+TIP and CLASPs to aid in viral spread (Jovasevic et al., 2015). Infected cell 
protein 0 (ICP0), which is a viral E3 ligase, has also been observed to 
destabilise and unbundle microtubules in Vero cells (green monkey kidney 
epithelial) (Naghavi et al., 2013). From a yeast two-hybrid screening, UL37 
and IKAP have been identified as interactors. IKAP has been suggested to 
stabilise microtubules (Cheishvili et al., 2011, Kelly et al., 2012). HSV-1 
infection has also been shown to remodel the microtubule network so that the 
centrosome is no longer the primary MTOC during egress, but additional mini 
MTOCs form, hypothesised to direct new progeny towards secondary 
envelopment sites (Pasdeloup et al., 2013a). These interactions show that 
during an Alphaherpesvirus infection the microtubule network is targeted and 
remodelled to facilitate viral spread. No evidence has been that MDV infection 








1.3: Cargo transport in cells 
 
The motor proteins that associate with microtubules belong to two major 
superfamilies of proteins: dyneins and kinesins (Fig 1.4). Dyneins mediate 
minus end-directed transport (Allan, 2011, Hook and Vallee, 2006). Kinesin 
superfamily proteins usually mediate plus end-directed motility (with some 
members capable of minus end-directed motility) (Hirokawa et al., 2009, 
Hirokawa and Tanaka, 2015). 
 
Dyneins are categorised in two classes based on their functional and structural 
roles: axonemal and cytoplasmic dyneins. Axonemal dyneins are involved in 
the flagella/ciliary beating (Roberts et al., 2013). Cytoplasmic dyneins are 
multi-subunit proteins with two heavy chains that each contain an N-terminal 
tail domain (adaptor/cargo binding domain), a motor domain and a microtubule 
binding domain. The motor domains of dyneins are ATPases associated with 
cellular activities (AAA+) units that regulate ATP binding, hydrolysis and 
release of ADP and inorganic phosphates.  ATP hydrolysis is coupled to 
dynein motor movement (Bhabha et al., 2016, Roberts et al., 2013). Three 
ubiquitous regulators of dynein activity have been identified; the dynactin 
complex (McKenney et al., 2014, Schlager et al., 2014), nuclear distribution E 
(NudE) and lissencephaly 1 (Lis1) (McKenney et al., 2011). Cytoplasmic 
dynein is responsible for transporting many types of vesicles (endosomes, 
phagosomes, lysosomes, etc.) towards the perinuclear region (Xiang et al., 
2015). Many different types of viruses depend upon dynein transport after viral 
entry and egress (Dodding and Way, 2011).  
 
The kinesin superfamily contains ~15 smaller families ordered by their 
phylogenic differences, and a total of 45 individual kinesin genes exist in 
humans (Hirokawa and Tanaka, 2015, Lawrence et al., 2004). The types of 
kinesins can be determined based on the location of the motor domain, which 
contains a microtubule binding site and the ATP catalytic domain for motility. 
N-kinesins have the motor domain on their N-terminus and are responsible for 
plus-end-directed transport. C-kinesins that have their motor domain on their 
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C-terminus and drive minus end-directed transport. M-kinesins contain their 
motor domain in the middle of the protein, and these kinesins are associated 
with depolymerising microtubules (Hirokawa et al., 2009). Besides the motor 
domain, kinesins contain a tail region that might contain regions for dimer 
formation, and domains responsible for binding to regulatory proteins, 
accessory kinesin light chains and/or cargo (Hirokawa et al., 2009). Kinesins 
can transport whole organelles, individual proteins, RNA molecules and 
vesicles (Hirokawa and Tanaka, 2015). They also play an essential role in 
cargo transport between the TGN to the plasma membrane and endoplasmic 
reticulum (ER) to the TGN (Hirokawa and Tanaka, 2015). There is also cargo 
that contains specific binding domains for specific kinesins. Adaptor proteins 
like JIP1 also aid in the recruitment and subsequent transport of cargo by 














Figure 1.4: Representative structures of kinesin and dynein motor proteins 
This figure is adapted from Carter (2013). Kinesins are microtubule motors and move towards 
the plus end of the microtubule (except for kinesin 14). The motor domain (dark blue) binds to 
the microtubule. The neck linker domain (light blue) along with the coiled-coil domains (red 
and yellow with grey) facilitate dimerization of two kinesin proteins. Cargo binding is facilitated 
by the kinesin tail (purple) and the kinesin light chains (green). Dynein is a processive dimeric 
motor that moves towards the minus end of the microtubule. Dynein binds to microtubules 
through the microtubule binding domain (light blue) present at the end of the stalk (grey, yellow 
and purple). The motor domain (dark blue) contains a ring of AAA+ domains. The N-terminal 
of the stalk associates with light chain, intermediate chain and light intermediate chain 










1.3.1: Cargo transporting kinesins 
There are three families of kinesins thought to carry out the bulk of the cargo 
transport needs of the cell; these are Kinesin-1, Kinesin-2 and Kinesin-3 
families. Most of what is known regarding kinesins has come from work carried 
out on Kinesin-1 family members (also known as conventional kinesin) 
(Lawrence et al., 2004). Minimal kinesin-1 motors that only contain the motor 
domain and dimerization domains can move processively (taking hundreds of 
steps without falling of the microtubule), towards the plus end of a microtubule 
at 8 nm step sizes (this is the distance between each tubulin dimer) at a speed 
of up to 0.8 µm/s-1 (Gennerich and Vale, 2009) Processivity is achieved by 
hand-over-head stepping mechanism in which the two motor domains from 




Figure 1.5: Minimal model of kinesin stepping  
There are four minimal states during the mechanochemical cycle of kinesin stepping. In state 
1 both motor domains are bound to the microtubule, the leading motor lacks a nucleotide and 
the trailing motor domain has a single ATP bound. Upon ATP hydrolysis and release of 
inorganic phosphate in the trailing motor domain, it detaches from the microtubule (state 2). 
ATP binding to the leading head results in forward docking of the neck linker, this results in 
bringing the trailing motor closer to the leading motor domain (state 3). The trailing motor then 
moves forward and binds on to the next available binding site on the microtubule. This 
releases the ADP molecule. The trailing motor domain is now the leading motor domain and 
the cycle continues (state 4).  Kinesin is represented by the blue and purple dimers, ATP is a 
yellow oval and ADP is orange and microtubule in green.  
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Kinesin-1 holoenzyme is a heterotetramer consisting of two kinesin heavy 
chains (KHC) and two kinesin light chains (KLC). The KHC contains the motor 
domain, neck domain, a coiled-coil stalk and a globular tail domain. The neck 
domain is critical to kinesin-1 processivity and contains a neck linker and neck 
coil. The coiled-coil stalk contains hinge segments that enable the motor to 
adopt folded and autoinhibited states and be flexible enough to accommodate 
multiple molecular motors to work together (Bieling et al., 2008, Coy et al., 
1999, Crevenna et al., 2008, Friedman and Vale, 1999, Jaud et al., 2006). The 
globular tail domain is responsible for regulating motor domain activity and 
cargo binding (Adio et al., 2006). The KLC subunit contains a heptad repeat 
region for oligomerisation with the KHC. This is followed by six 
tetratricopeptide repeat (TPR) motifs that participate in cargo binding. The 
KHCs are encoded by Kif5A, Kif5B and Kif5C genes and KLC are encoded by 
four genes (KLC1-4).  
 
The kinesin-2 family contains a further two sub-families that are heterotrimeric 
or homodimeric. The heterotrimeric kinesin-2 motors are made up of two 
motor-domain-containing subunits from the Kif3 sub-family and a nonmotor 
kinesin-associated protein (KAP). The homodimeric sub-family contains Kif17. 
Both sub-families of kinesin-2 have been implicated in a wide range of 
transport events: long distance transport during construction and maintenance 
of cilia and flagella, transport of organelles (mitochondria), melanosomes, 
mRNA granules, and membrane-bound vesicles (Hirokawa et al., 2009, 
Scholey, 2008) 
 
Kinesin-3s have been identified as organelle, endosome and vesicle 
transporters (Siddiqui and Straube, 2017). The kinesin-3 family is comprised 
of 6 sub-families: Kif1, Kif13, Kif14, Kif16 and Kif28 motors, plus a small group 
of fungal Kinesin-3 like short proteins (Miki et al., 2005). Kinesin-3 is the largest 
family of kinesins in humans. Kinesin-3 facilitated transport is essential for 
neuronal morphogenesis and function. Mutations in Kif1A, Kif13B and Kif1C 
are known to cause neurological disorders, including spastic paraplegia and 
multiple sclerosis (Aulchenko et al., 2008, Caballero Oteyza et al., 2014, Dor 
et al., 2014, Niwa et al., 2008, Yonekawa et al., 1998) For example, Kif13B 
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(also known as; guanylate kinase-associated kinesin (GAKIN)) has been 
shown to transport vesicles containing PtdIns(3,4,5)P3 (phospholipid), human 
discs large (hDlg) tumour suppressor protein, vascular endothelial growth 
factor receptor 2 (VEGFR 2) and transient receptor potential vanilloid 1 
(TPRV1) in rat adrenal gland cells, rat dorsal neurons human endothelial cells 
(Horiguchi et al., 2006, Xing et al., 2012, Yamada et al., 2007, Yamada et al., 
2014). 
 
All kinesin-3 family motors are plus end-directed motors. The defining features 
of Kinesin-3 motors are the molecular organisation of the neck –region. It 
contains a β-sheet, a helix and a forkhead-associated (FHA) domain in the tail 
region (Westerholm-Parvinen et al., 2000).  The tail region also contains 
several short coiled-coil domains and lipid interaction domains thought to 
mediate cargo binding (Siddiqui and Straube, 2017).  
 
The motor domain of kinesin-3s contains a stretch of positively charged lysine 
residues termed the K-loop. This loop is positioned to contact the negatively 
charged glutamate-rich (E-hook) C-terminal tail of β-tubulin. The K-loop in Kif1, 
Kif13 and Kif16 proteins have been shown to increase microtubule affinity to 
motor domains, this increases microtubule binding rate and ensures kinesin-
3s can effectively work in teams (Matsushita et al., 2009, Rogers et al., 2001, 
Soppina and Verhey, 2014). 
 
Kinesin-3 does not contain the extended coiled-coils observed in other kinesin 
families. There are instead smaller predicted coiled-coil regions scattered 
along the tail domain. With Kif13A, Kif13B and Kif1A, the coiled-coil domains 
interfere with dimerisation, and the neck coil is sufficient to dimerise kinesin-
3s (Hammond et al., 2009, Soppina et al., 2014). The FHA domain found on 
kinesin-3s has been shown to be important for cargo binding. The FHA domain 
on Kif13B is essential for binding TRPV1 (Xing et al., 2012). This interaction 
has been shown to be dependent on phosphorylation of Kif13B at T506 in the 
FHA domain by cyclin-dependent kinase 5 (Cdk-5) (Xing et al., 2012). Kif1A 
and Kif13B also have a pleckstrin homology (PH) domain that is important for 
binding vesicles. This is mediated by phosphatidylinositol 4,5-bisphosphate 
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(PtdIns(4,5)-P2) (Klopfenstein et al., 2002, Xue et al., 2010). Kif13B also 
processes a protein interaction domain CAP-Gly thought to bind to sequence 
motifs at the C-terminus of tubulin and EBs, zinc-finger motifs, and proline-rich 
sequences (Steinmetz and Akhmanova, 2008). Inactive kinesin-3s are 
compact and have a crumpled tail (Hirokawa and Noda, 2008). This is termed 
autoinhibition (Okada and Hirokawa, 1999, Tomishige et al., 2002).  
 
Kinesins are activated by cargo binding. Kif13B is in an autoinhibited state in 
solution and is activated by cargo binding, e.g., hDlg tumour suppressor. 
Kif13B is also active during in vitro gliding assay – this could be due to the tail 
region being bound to the glass surface and glass taking over the role of cargo 
(Yamada et al., 2007).  Centaurin α1 (CENTA1) is a cargo adapter for Kif13B. 
It activates Kif13B from its auto-inhibited state and recruits it to PtdIns(3,4)P2 
/ PtdIns(3,4,5)P3-containing vesicles. The PH1 domain of CENTA 1 directly 
interacts with the FHA domain on Kif13B. The FHA domain also interacts with 
the ArfGAP domain of a second CENTA1 molecule. Kif13B and CENTA1 form 
a heterotetrameric complex for the transport of PtdIns(3,4,5)P3-rich vesicles 
(Horiguchi et al., 2006, Tong et al., 2010).  
 
Kinesin-3 has also been suggested to be involved in the bi-directional 
transport of cargo. When depleting a specific kinesin-3, the transport of cargo 
towards both ends of the microtubule is impaired (Ally et al., 2009, Theisen et 
al., 2012, Tien et al., 2011). Kinesin-3s have been suggested to transport 
cargo together with dynein, but the exact mechanism of this remains unknown 
(Hancock, 2014). The opposing force/lack of force generated could result in 
mechanical activation of the partner motor (Ally et al., 2009). It could also be 
the steric inhibition mechanism where direct interactions between the 
opposing motors relieve autoinhibition. There could also be a tether 
mechanism were the opposing motor acts as a weakly bound tether to 
increase processivity (Hancock, 2014).  
 
A tug-of-war model has also been proposed for bi-directional transport. The 
motors pull against each other, and generally, the strongest team of motors 
wins resulting net movement of cargo towards the winning end. The outcome 
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was determined by the numbers of each motor protein and the force that each 
motor can produce (Amrute-Nayak and Bullock, 2012, Derr et al., 2012). 
Potential linkers of both kinesin -3 and dynein could be Hook and Bicaudal 
proteins as both have been identified to interact with both types of motors 
(Bielska et al., 2014, Fu and Holzbaur, 2014, Schlager et al., 2010, Splinter et 
al., 2010). Kinesin binding protein (KBP) could also form the bridge between 
dynein and kinesin-3 as it has been shown to inhibit Kif1A bi-directional 
transport and stimulate Kif1B bi-directional transport (Drerup et al., 2016, 
Kevenaar et al., 2016). 
 
Microtubule based motor proteins are essential for the long-distance transport 
in eukaryotic cells. They are also essential for the life cycle of many different 
viruses like adenovirus, vaccinia virus and HSV-1 (Antinone et al., 2010, 
McDonald et al., 2002, Schepis et al., 2007, Suomalainen et al., 1999). The 
most detailed image for dynein and virus interaction comes from studies on 
the role of dynein and microtubules in the adenovirus life cycle. By labelling 
fluorescently adenovirus particles it was possible to visualise microtubule 
mediated bi-directional transport during the early phases of adenovirus 
infection and treating these cells with nocodazole results in significant 
reduction in adenovirus nuclear targeting (Leopold et al., 2000, Salinas et al., 
2009, Suomalainen et al., 1999). Disruption of dynein activity by over 
expression of dynactin subunit p50/dynamitin or the coiled-coil region of 
p150glued also results in reduced incidence of virus directed transport towards 
the nucleus (Engelke et al., 2011, Salinas et al., 2009). Kinesin 1 has been 
shown to be important for vaccinia virus infections, intracellular enveloped 
virus (IEV) are transported from the perinuclear region towards the plasma 
membrane on microtubules (Roberts and Smith, 2008). This transport is 
dependent on viral protein A36 and in the absence of A36 IEV fail to reach the 







1.3.2: Alphaherpesvirus interactions with the host molecular motors 
The majority of Alphaherpesvirus viral proteins that are associated with 
microtubules in one form or another have been shown to engage not with 
microtubules directly but with microtubule-dependent molecular motors. 
Intracellular pathogens generally require kinesin/dynein mediated intracellular 
transport. Therefore, many pathogens, including Alphaherpesviruses, have 
developed mechanisms of subversion of these molecular motors (Dodding 
and Way, 2011, Dohner et al., 2005, Smith et al., 2001, Taylor and Enquist, 
2015, Ward, 2011).  
 
There are currently two working models for Alphaherpesvirus trafficking during 
egress in neurons. The subassembly model: where naked capsid lacking an 
envelope is being transported. The second is the married assembly model, 
where a capsid has undergone secondary enveloping and processes a viral 
envelope is then transported (Miranda-Saksena et al., 2018). The model of 
transport chosen reflects which viral proteins are accessible for interaction with 
host molecular motors during transport. During enveloped capsid transport the 
tegument and capsid proteins will be inaccessible for interactions with 
molecular motors, but viral glycoproteins will be accessible for interaction. 
Both naked and enveloped viral particles have been shown to undergo 
directional transport on microtubules (Antinone and Smith, 2006, Antinone et 
al., 2010, Wisner et al., 2011). These models are based in neuronal cells, 
however the mode of transport exploited by the virus in neurons may also be 
used as a starting point to try and understand viral capsid transport in non-
neuronal cells. 
 
Most of the research into Alphaherpesvirus viral protein interactions with host 
microtubule-associated motors and accessory proteins has been carried out 
using HSV-1, HSV-2 and PRV viruses. There has been a small number of viral 
proteins that have been shown to interact with dynein directly or with dynein 
recruitment proteins (Fig 1.6). UL34 from HSV-1 has been shown to interact 
with dynein intermediate chain 1a (IC-1a), UL34 has been shown to be a non-
structural protein that localises to the nuclear membrane (Loret et al., 2008, 
Ye et al., 2000).  UL35, a viral capsid protein, from HSV-1 has been shown to 
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interact with dynein light chains Tctex1 and RP3 in a yeast two-hybrid assay. 
Micro-injection of HSV-1 UL35 enhanced retrograde transport of viral particles. 
However, deletion studies have suggested that these interactions are 
dispensable in cells (Antinone et al., 2006, Dohner et al., 2006, Douglas et al., 
2004). UL36, a tegument protein, from PRV has also been shown to interact 
with the dynein/dynactin complex (Zaichick et al., 2013). This interaction was 
shown to drive active transport of viral particles in the absence of other viral 
proteins in Vero cells. The viral capsid protein UL25 is also thought to be 
necessary for this interaction as UL36 is thought to bridge together the 
dynein/dynactin complex with the viral capsid. The proline-rich domain of UL36 
binds UL25 (Zaichick et al., 2013).    
 
Kinesin 1 and 3 family members also facilitate Alphaherpesvirus capsid 
transport (Fig 1.6). US11, tegument protein from HSV-1, has been suggested 
to interact with kinesin-1 directly. This interaction is achieved by 867-894 
residues on kinesin-1 directly binding to the C-terminal domain (RNA binding 
domain) of US11 (Diefenbach et al., 2002). Additionally, viral protein US9 from 
HSV-1 has been shown to interact with kinesin-1. Five arginine residues in the 
basic domain of US9 are thought to facilitate this interaction. This domain was 
also shown to contribute to the anterograde transport of viral particles in rat 
dorsal neurons (Diefenbach et al., 2016). RNAi mediated knockdown of 
kinesin-1 family members Kif5A, 5B and 5C (individually) all halt anterograde 
transport of enveloped HSV-1 viral particles in neuronal cells (DuRaine et al., 
2018) 
 
PRV and HSV-2 viral particles are transported by kinesin-3 family member 
Kif1A. The viral protein UL56 of HSV-2 has been shown to interact with Kif1A 
C-terminal transmembrane domain in Vero cells (Daniel et al., 2016, 
Koshizuka et al., 2005). The US9 protein from PRV has also been shown to 
interact with Kif1A using a GFP-trap pull-down. This interaction was further 
solidified by showing that Kif1A interaction with PRV viral particles results in 
efficient axonal sorting and transport in rat neurons (Daniel et al., 2015, 
Kramer et al., 2012). UL37 (tegument protein) from HSV-1 recruits 
dystonin/BPAG1 to viral capsids in human fibroblast cells. Depleting dystonin 
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has been shown to inhibit plus-end-directed transport of viral particles, and 
this is thought to be necessary for the transport of incoming viral particles from 
the centrosome towards the nucleus and during egress (McElwee et al., 2013, 
Pasdeloup et al., 2013b) Thus, Alphaherpesvirus proteins UL36, US9 and 
US11 are all emerging as viral proteins that interact with host molecular motors 















Figure 1.6: Dynein and kinesin motors transport Alphaherpesvirus particles 
Alphaherpesvirus viral particles have been suggested to be transported by numerous host 
microtubule associated molecular motors. These include dynein, kinesin-1 and kinesin-3. 
HSV-1 uses viral proteins UL34 and UL35 to recruit dynein to the viral capsid during entry. It 
has also been shown to recruit kinesin-1 motor via US11 and US9 during anterograde 
transport. PRV recruits dynactin to viral capsids during entry via interaction with UL36 which 
in turn brings dynein. Kinesin-3 is recruited to PRV viral particles via US9 during anterograde 










1.4: Marek's Disease Virus (MDV)  
Marek's Disease Virus (MDV) otherwise known as Gallid Herpesvirus 2 
(GaHV-2) is an Alphaherpesvirus found in the family Herpesviridae. MDV is 
found in the genus Mardivirus. MDV is the causative agent of the highly 
infective lymphoproliferative disease called Marek's Disease (MD) (Nair, 
2005). MDV infects many birds that are part of the Phasianidae family and 
results in a high mortality rate in Gallus gallus domesticus (Common poultry). 
This virus was first isolated in 1968 (Churchill, 1968) and Josef Marek first 
described this virus in 1907 as the causative agent of polyneuritis and as 
affecting mainly old chickens with low and negligible mortality. However, this 
is no longer the case as MDV infection mortality has risen drastically with 
severe symptoms like strong immunosuppression, tumours, and neurological 
disorders (Gimeno, 2008). The ever-rising virulence of MDV infection is 
leading to growing concerns over potential outbreaks due to the fact that 
evolution towards higher virulence in response to vaccine usage has occurred 
multiple times in the past (Nair, 2005). This is further elevated by the reduced 
genetic diversity across the poultry industry (Cheng et al., 2008). Novel 
therapeutic targets are required.  
 
Some of the unique features that differentiate MDV from other 
Alphaherpesviruses is that it is strictly cell-associated (Nazerian et al., 1968), 
encodes an oncogene (Meq) within its own genome (Jones et al., 1992), 
establishes latency in lymphocytes (Shek et al., 1983) and is able to induce 
lymphomas (Biggs and Payne, 1967). There are three serotypes of MDV, and 
each of these serotypes has significant differences both in the genome and 
biological features. Serotype 1 (RB1B) MDV is a common wild-type virus that 
includes all oncogenic strains and their attenuated forms. Serotype 2 is the 
non-oncogenic virus isolated in chickens. Serotype 3 is the non-oncogenic 
virus isolated from turkeys generally known as herpesvirus of turkeys (HVT) 
(Gimeno, 2008). Viral cloning, the introduction of overlapping viral genomic 
fragments into a bacterial artificial chromosome (BAC) vector, has proven to 
be an indispensable research tool for the MDV field (Zelnik, 2003). The MDV 
genome is about 175 kb with a circular structure and consists of several 
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regions, unique long (UL) and unique short (US) regions are flanked by 
terminal repeats long (TRL), short (TRS) and internal repeats long (IRL) and 
short (IRS) domains (Zelnik, 2003).  
 
MDV infection starts with inhalation of viral particles shed from the feather 
follicles of infected birds. Within 24-hours of contact with the lungs, the viral 
genome can be detected in the spleen, thymus and bursa of the infected bird 
(Schat et al., 1984). This efficient transmission of the viral infection from the 
lungs is attributed to infected macrophages in the lung, which transfer the 
infection to B lymphocytes (Baaten et al., 2009, Barrow et al., 2003, Calnek, 
2001). All viral movement throughout the infected bird is achieved via cell-
associated viral spread; unenveloped MDV is not infective (Nazerian et al., 
1968). MDV infection occurs in four distinct stages, early cytolytic, latent, late 
cytolytic and transformation (Addinger and Calnek, 1973, Osterrieder et al., 
2006). During the early cytolytic infection stage, the virus replicates in 
macrophages and T and B lymphocytes, and after 7-days latency is 
established in T-lymphocytes (Arumugaswami et al., 2009, Trapp et al., 2006). 
Latently infected T-lymphocytes are capable of being transformed by the viral 
infection, facilitated by the Meq viral oncogene 14-21-days post infection. This 
results in the formation of lymphomas in visceral organs (Burgess and 
Davison, 2002, Calnek, 2001, Nair, 2005, Osterrieder et al., 2006, Trapp et al., 
2006, Witter, 1997). Eventually, the feather follicle epithelium (FFE) becomes 
infected via peripheral lymphocytes (Johnson et al., 1975). FFE is the only cell 
type that can produce mature cell-free MDV virions that can persist in the 
external environment and infect a new host (Calnek, 2001, Osterrieder et al., 
2006).  
 
1.4.1: MDV interactions with the host cytoskeleton 
There are only two papers in the literature that investigate microtubules in the 
context of MDV infection. The first paper shows that tegument protein VP22 
co-localises with microtubules. The N-terminal truncation mutants of VP22 can 
still co-localize with microtubules (O'Donnell et al., 2002). Schumacher et al. 
(2005) used a viral plaque assay to conclude that microtubules are 
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dispensable for MDV viral spread. This conclusion was reached after MDV 
viral plaque size and plaque number had not changed compared to control 
after treating a BAC20 (recombinant wild type MDV) transfected CEF 
monolayer with nocodazole (microtubule depolymerising drug) for five days. 
This observation is probably the reason why no further research has been 
carried out on MDV and its possible association with microtubules.  
 
Schumacher et al. (2005) also suggested that US3 from MDV is required for 
efficient de-envelopment of perinuclear viral particles and plays a role in actin 
stress fibre breakdown in the late stages of viral infection. This was also shown 
in HSV-1 infection (Wild et al., 2015). They also used Cytochalasin D (F-actin 
depolymerising drug) to demonstrate that F-actin is essential for MDV viral 
spread in a plaque assay. The same group went on to further characterise the 
role of US3 by generating a point mutation in the BAC20 US3 gene to mutate 
its kinase domain. Phosphorylation of pp38 (MDV-specific lytic 
phosphoprotein) was inhibited in this mutant and had the same growth 
properties as the US3 deletion with primarily enveloped virions found to 
accumulate at the perinuclear space (Schumacher et al., 2008). However, the 
mutation of the catalytic domain did not affect the ability of the virus to 
modulate the actin cytoskeleton. This suggested that US3 modulation of the 
actin network is independent of US3 kinase activity. Richerioux et al. 2012 
have pursued the findings that cytochalasin D treatment of viral plaques 
results in smaller and fewer MDV plaques. They show that Jasplakinolide 
which promotes actin polymerisation also significantly reduced viral plaque 
area. Inhibiting the Rho and ROCK signalling pathways results in smaller viral 
plaques and inhibiting Rac signalling with inhibitors results in larger viral 
plaques (Richerioux et al., 2012). Beta-actin mRNA expression is also 
increased 2-fold during MDV infection (Neerukonda et al., 2016). These 
papers suggest that microtubules may be dispensable during MDV infection, 
but that actin is essential and requires fine modulating by the US3 protein. 
However, many other Alphaherpesviruses rely on the host microtubule 
network for efficient infection and it is unlikely that an entirely cell-associated 




1.5: Outline of this work  
 
Based on the extensive literature regarding microtubule-based transport of 
Alphaherpesviruses it would be surprising that MDV infection would not be 
associated with microtubules. Therefore, it was important to reinvestigate the 
role of microtubules in MDV infection, and to determine if and how MDV 
particles are transported along them.  
 
The first aim was to establish whether MDV infection depends on 
microtubules. To achieve this, viral plaque assays with small molecule 
inhibitors were used to first determine the importance of microtubules. Then, 
infected cell shape was analysed and the relevance of dynamic microtubules 
for cell shape was elucidated. The possible role of PTMs during MDV infection 
was also studied. 
 
In the next step we aimed to determine whether MDV viral particles are 
associated with microtubules in the cytoplasm. To achieve this, fluorescently 
labelled viral capsid proteins were used in super-resolution microscopy 
experiments to show viral capsid transport along microtubules and describe 
their dynamic characteristics. Electron microscopy was used to determine the 
native state (i.e., naked or enveloped) of MDV particles in the cytoplasm.  
 
Finally, we attempted to identify the microtubule motor proteins that are 
responsible for transporting MDV viral particles. This was achieved by using a 









Chapter 2: Methods 
 
2.1: Molecular Biology 
 
2.1.1: Polymerase Chain Reaction (PCR) 
PCR amplification was carried out using high-fidelity Phusion Taq or Taq DNA 
polymerase (NEB, UK) for cloning and gene expression analysis. The PCR 
mix was prepared to a total volume of 50µl (Table 1) and amplified in a 
Biometra T3000 thermocycler using conditions in Table 2. Primers used are 
detailed in Table 3 and combinations of primers used in Table 4.  PCR product 
amplification was confirmed by visualising 10 µl reaction mix with 2 µl 6x 
Orange G loading buffer on a 1% agarose gel containing safeview (1 µl:20 ml) 
on a UV table. Product sizes were compared to GeneRuler 1kb ladder 
(Fermentas). When required, PCR products were purified using PCR 
purification kit (BioBasic) or spin column gel extraction kit (BioBasic) in 
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Table 2: PCR cycling conditions 
 
 
Primer Name Sequence Experiment used/chapter 
AS701_chKif13B_Fwd(1) 
Pos: 2966 (nt) 
TAT GGG CAC AAG 
CAG AGT GG 
5.1 
Confirming shRNA mediated 
knockdown 
AS702_chKif13B_Rev(1) 
Pos: 3179 (nt) 
CGA GAT TGC CCC 
TGT CTG AG 
5.1 
Confirming shRNA mediated 
knockdown 
AS703_chKif13B_Fwd(2) 
Pos: 4458 (nt) 
CTG ATG CAG GTC 
TGG GTA GC 
5.1 
Confirming shRNA mediated 
knockdown 
AS704_chKif13B_Rev(2) 
Pos: 4729 (nt) 
TGG GCA TCT TTT 
CGG GAC TC 
5.1 
Confirming shRNA mediated 
knockdown 
AS705_chKif13B_Fwd(3) 
Pos: 4264 (nt) 
TGT GAA TCG GCT 
TTC TGC GA 
5.1 
Confirming shRNA mediated 
knockdown 
AS706_chKif13B_Rev(3) 
Pos: 4510 (nt) 
TTG GCA TCT GAG 
GCA CGA AT 
5.1 
Confirming shRNA mediated 
knockdown 
AS707_chGAPDH_Fwd(1) 
Pos: 833 (nt) 
GAG GAC CAG GTT 
GTC TCC TG 
5.1 
Confirming shRNA mediated 
knockdown 
AS708_chGAPDH_Rev(1) 
Pos: 1038 (nt) 
TCC TTG GAT GCC 
ATG TGG AC 
5.1 




Table 3: Primers used in this study. 
2.1.2: RNA extraction and RT-PCR 
DF-1 cells transfected with pSuper-CherryTub-shKifX plasmids were grown 
for RNA expression in 6 well plates. Transfection efficiency was checked on 
Olympus IX71 inverted fluorescence microscope with Deltavsion system 
(Applied Precision LLC) using mCherry filters. Only when the transfection rate 
was above 70%, the cells were harvested. Transfected DF-1 cells were 
trypsinized, and cell pellets were washed with PBS twice at RT by 
centrifugation at 500xg for 3 minutes. 1.4ml TRIzol reagent (ThermoFisher 
Scientific) was added to the cell pellet. The pellet was vortexed until entirely 
re-suspended. After 5 minutes of incubation at RT; 300 µl of chloroform was 
added to the cell extract. This was vortexed and incubated for 5 minutes at 
RT. The mixture was centrifuged for 10 minutes at 12,000 xg at RT. The clear 
top layer was then taken and mixed with 700µl of isopropanol through 
AS709_chGAPDH_Fwd(2) 
Pos: 51 (nt) 
AGG CGA GAT GGT 
GAA AGT CG 
5.1 
Confirming shRNA mediated 
knockdown 
AS710_chGAPDH_Rev(2) 
Pos: 275 (nt) 
GGT CAC GCT CCT 
GGA AGA TAG 
5.1 
Confirming shRNA mediated 
knockdown 
AS711_chGAPDH_Fwd(3) 
Pos: 275 (nt) 
CTA TCT TCC AGG 
AGC GTG ACC 
5.1 
Confirming shRNA mediated 
knockdown 
AS712_chGAPDH_Rev(3) 
Pos: 429 (nt) 
TCA CAA ACA TGG 
GGG CAT CA 
5.1 
Confirming shRNA mediated 
knockdown 
AS713_chKif13A_Fwd(1) 
Pos: 49 (nt) 
AGG AGA GAG CTG 
GAG CTG AA 
5.1 
Confirming shRNA mediated 
knockdown 
AS714_chKif13A_Rev(1) 
Pos: 351 (nt) 
GAC CCA GCT GCT 
CTG CAT TA 
5.1 
Confirming shRNA mediated 
knockdown 
AS715_chKif13A_Fwd(2) 
Pos: 350 (nt) 
GTA ATG CAG AGC 
AGC TGG GT 
5.1 
Confirming shRNA mediated 
knockdown 
AS716_chKif13A_Rev(2) 
Pos: 494 (nt) 
CTG CCG ACT CCC 
TTT TGG AT 
5.1 
Confirming shRNA mediated 
knockdown 
AS717_chKif13A_Fwd(3) 
Pos: 370 (nt) 
CTG ATC CCA CGG 
CTC TGT TG 
5.3 
Confirming shRNA mediated 
knockdown 
AS718_chKif13A_Rev(3) 
Pos: 492 (nt) 
GCC GAC TCC CTT 
TTG GAT CA 
5.1 
Confirming shRNA mediated 
knockdown 
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inversion and incubated at room temperature (RT) for 10 minutes. RNA was 
precipitated by 10 minutes of centrifugation at 12,000 xg at RT. The 
supernatant was discarded, and the pellet was washed with 70% ethanol. This 
was then centrifuged for 5 minutes at 7,500 xg at RT. The supernatant was 
discarded, and the pellet was air dried. The pellet was re-suspended in 40 µl 
nuclease –free ddH20 and then incubated at 50ºC for 20 minutes. RNA was 
stored at -20 ºC. 
 
Purified RNA was then immediately used to synthesise cDNA. 0.2 µg of 
random hexamer primers were mixed with 10 mM dNTP mix, and 1 µg of total 
RNA. This was made up to 12 µl in nuclease free ddH2O and heated to 65ºC 
for 5 minutes before quickly chilling for 2 minutes in ice. Next, first strand buffer 
was added to a final concentration of 1x, along with DTT to a final 
concentration of 1 mM. This mixture was incubated at RT for 5 minutes, and 
then 200 U of M-MLV Reverse transcriptase polymerase was added to the 
mix. This was mixed and incubated at RT for 10 minutes. The mixture was 
then incubated at 37 ºC for 50 minutes and then heat inactivated at 70 ºC for 
15 minutes. This cDNA was then stored at -20ºC until it was used as a template 
for PCR. 
Primer pairs Expected band size and source 
AS701 + AS702 233 bp cDNA from DF-1 cells 
AS703 + AS704 291 bp cDNA from DF-1 cells 
AS705 + AS706 266 bp cDNA from DF-1 cells 
AS707 + AS708 173 bp cDNA from DF-1 cells 
AS709 + AS710 245 bp cDNA from DF-1 cells 
AS711 + AS712 174 bp cDNA from DF-1 cells 
AS713 + AS714 313 bp cDNA from DF-1 cells 
AS715 + AS716 164 bp cDNA from DF-1 cells 
AS717 + AS718 142 bp cDNA from DF-1 cells 
 
Table 4: Primer pair combinations used and expected product sizes 
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2.1.3: Cloning  
PCR products were digested with restriction enzymes from NEB (used 
according to manufacturer’s instructions), or genes/markers were digested out 
of previously made constructs. The backbone plasmids were also restriction 
enzyme digested. These backbone vectors and inserts were separated on an 
agarose gel bands cut out and DNA fragments were extracted using a spin 
column gel extraction kit (BioBasic). The fragments were then ligated for 10 
minutes at RT using T4 DNA ligase in rapid ligation buffer (Thermo Scientific).  
 
Chemically competent TOP10 cells were made by picking a single colony of 
TOP10 cells and growing overnight in 3ml DYT media (16 g/L tryptone, 10 g/L 
yeast extract and 5 g/L NaCl, pH 7). 3ml of culture of TOP10 cells was then 
added into 600ml fresh DYT media supplemented with 20 mM MgSO4. Culture 
was grown until OD600 = 0.48. At this point onwards, everything was carried 
out in a cold room and all equipment was precooled. TOP10 cells were then 
pelleted at 2000 xg at 4ºC. Supernatant was discarded, and pellet was 
suspended in 180 ml Tfb1 buffer (30 mM KAc, 50 mM MnCl2, 100 mM RbCl, 
10 mM CaCl2, 15% v/v glycerol, pH 5.8 (adjusted with HAc)) and incubated on 
ice for 5 minutes. Cells were then pelleted at 1000 xg for 10 minutes at 4ºC. 
Supernatant was discarded, and the cell pellet was resuspended in 8 ml Tbf2 
buffer (10mM 3-(N-morpholino)propanesulfonic acid (MOPS) (pH 7), 75 mM 
CaCl2, 10 mM, RbCl, 15% v/v glycerol, pH 7.0 (adjusted with NaoH)) and was 
incubated on ice for 15 minutes. The TOP10 cells were then aliquoted and 
snap frozen in liquid N2 and stored at -80ºC.  
 
Chemically competent TOP10 cells were transformed by adding the ligation 
product to thawed cells. These were incubated on ice for 20 minutes. Then 
heat-shocked at 42ºC for 45s. The transformed cells were allowed to recover 
for 1 hour at 37ºC in SOC medium (0.5% Yeast Extract, 2% Tryptone,10 mM 
NaCl, 2.5 mM KCl, 10 mM MgCl2, 10mM MgSO4, 20 mM Glucose, pH 7). The 
cells were pelleted at 2000 xg for 5 minutes at RT, re-suspended in 100 µl 
SOC, and then plated on to LB agar plates containing the appropriate 
antibiotic. The plate was placed in 37ºC overnight (ON). Single colonies from 
the plate then picked and grown in 3 ml DYT media overnight. Plasmid DNA 
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was extracted using Mini-prep spin column kit (BioBasic). The positive clones 
were further confirmed by restriction digest and sanger sequencing.  
 
2.1.4: Construction of shRNA plasmids  
Firstly, target sites were determined using RNAi Central 
(http://cancan.cshl.edu/RNAi_central/RNAi.cgi?type=shRNA). Then 19 base 
pairs from the start of the site was used to design forward and reverse oligos 









The matching pairs were then annealed by mixing 5 mM final concentration of 
each oligo along with 1x T4 ligase buffer in 30 µl total volume. The mixture 
was then incubated at 94ºC for 4 minutes then cooled down to 60 ºC at 0.01 
ºC/s and then to 4 ºC at a rate of 0.03 ºC/s. To phosphorylate ends, 1x 
Polynucleotide Kinase (PNK) buffer, 0.5mM ATP and 20U PNK final 
concentrations were added in a final volume of 50 µl. The mixture was 
incubated at 37ºC for 1 hour. These double-stranded DNA fragments were 
then cloned into pSuper_NeoGFP expression plasmid (Oligoengine) digested 
with BglII and XhoI restriction enzymes (NEB). Colonies were picked and 
screened using restriction enzymes BglII and NcoI (NEB). The successful 
insert was checked using Sanger sequencing. 
 
The Neo_GFP tag was replaced with a mCherry Tubulin tag. This was 
achieved by digesting both the newly made pSuper_shKifx_NeoGFP and 
pSuper-mCherryTubulin_EB3 (Straube and Merdes, 2007) plasmids with 
BamHI and Nhel restriction enzymes. The 2089 base pair (bp) band from 
pSuper_mCherryTubulin_EB3 and 3718 band from pSuper_shKifx_NeoGFP 
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plasmids were then ligated. The correct insert was confirmed by restriction 
enzyme digest using XhoI (NEB), Sanger sequencing, and transfection of 












Kif5C motor domain with a tdTomato and FKBP tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc- 
Kif 1a 395-1695 
Kif1a tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-Kif 
1B alpha tail 
Kif1Ba tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-Kif 
1b Beta 386-1770 
Kif1Bb tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-Kif 
5c tail 
Kif5C tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-Kif 
17 400-1038 
Kif17 tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-Kif 
21B tail 
Kif21B tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-
mmKif 13A tail 
Kif13A tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pBa-FRB-3myc-
mmKif13B tail 
Kif13B tail domain with 3myc and FRB tag 
Provided by Banker Lab (OHSU) 
Split kinesin 
assay / 5.1 
pSuper_shKif13A(
1)_mCherryTub 
A plasmid expressing shRNA against target 
sequence: AGCCAGTGAAGCTTCTTCA (Kif13A) 
with mCherryTub expressed independently 







A plasmid expressing shRNA against target 
sequence: GAAGTCTGGAAGTCATGGA 
(Kif13A) with mCherryTub expressed independently 







A plasmid expressing shRNA against target 
sequence: CCACACACTTTATGATGTG (Kif13B) 
with mCherryTub expressed independently 







A plasmid expressing RNAi against target sequence: 
GATGACTTTAGCTCCCAAG (Kif13B) with 
mCherryTub expressed independently 









A plasmid expressing shRNA against target 
sequence CGTACGCGGAATACT TCGA 








A plasmid expressing shRNA against target 
sequence: AGCCAGTGAAGCTTCTTCA (Kif1B) with 
mCherryTub expressed independently 








A plasmid expressing shRNA against target 
sequence: TGGGCCAGAGTGTGAGCAA (Kif1B) 
with mCherryTub expressed independently 







A plasmid expressing shRNA against target 
sequence: AAGTATCCTACATGGAGAT (Kif13A+B) 
with mCherryTub expressed independently 
Designed to knock down both Kif13A and B 







A plasmid expressing shRNA against target 
sequence: ATCCTACATGGAGATATAC (Kif13A+B) 
with mCherryTub expressed independently 
Designed to knock down both Kif13A and B 







A plasmid expressing shRNA against target 
sequence: TCCCAGACAATCTCGTGTC (Kif21B) 
with mCherryTub expressed independently 







A plasmid expressing shRNA against target 
sequence: ACCCAAATAATGTCGTTTC (Kif21B) 
with mCherryTub expressed independently 






Table: 5 Plasmids used in this study 
 
2.1.5: Western Blotting  
Western blotting was carried out by running whole cell extracts on 
polyacrylamide gels (see Table 6 for full details). The gels were cast between 
two glass slides. First the separating gel was poured, allowed to polymerise 
and then followed by the stacking gel. A comb was inserted, and the gel was 
allowed to polymerise for 30 minutes at RT. Each well was loaded with whole 
cell extracts containing 1x Laemmli protein buffer (2% SDS, 62.5mM Tris-HCl 
pH 6.8, 25% glycerol, 0.01% Bromophenol Blue and 5% β-mercaptoethanol) 
The gel was ran at 16 mA per gel in the tank for 90 minutes at RT in gel running 
buffer (25 mM Tris, 192 mM glycine, 0.1% SDS).  The proteins on the gel were 
then transferred to a nitrocellulose membrane by electroblotting at 400mA for 
90 minutes in transfer buffer (25 mM Tris, 192 mM glycine, 10% methanol). 
The membranes were then blocked with 5% milk in PBS and then incubated 
in primary antibody overnight at 4oC in 0.5% milk in 0.1%Tween in PBS 
(PBST). The membrane was then washed with PBST three times, 10 minutes 
each. The membrane was then treated with each species-specific secondary 
antibody conjugated to horseradish peroxidase (HRP) for an hour at RT. The 
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membrane was washed with PBS 3x, 10 minutes each. The membrane was 
then developed with pico or femto chemiluminescence kit and exposed to film 
















percentage 8 10 12 15 
ddH20 (ml) 5.3 4 3.3 2.3 
Seperation buffer 
(Tris-HCL (1.5 M, 
pH 8.8 , 10% SDS) 
(ml) 





2.67 3.33 4 5 
10% Ammonium 











(0.5 M, pH 
















2.7 1.13 0.6 80 8 
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Antibody name / clone / source Dilutions Target 






Anti a –tubulin with Alexa Flour 647 
congregate 






Anti a -tubulin 















Anti Poly Glutamate modification 
tubulin 




WB 1:4000 Anti poly Glutamate chains 




IF 1:5000 Anti GFP antibody from chicken 




WB 1:4000 Secondary antibody from goat anti mouse with a HRP conjugate 
Goat anti rabbit IgG 
Promega W401B 
 
WB 1:4000 Secondary antibody from goat anti rabbit with a HRP conjugate 
Donkey anti rabbit IgG Alexa 488 
Molecular Probes A-21206 IF 1:500 
Secondary antibody anti rabbit with 
Alexa 488 label 
Donkey anti rabbit IgG Alexa 594 
Molecular Probes A-21207 IF 1:1000 
Secondary antibody anti rabbit with 
Alexa 594 label 
Donkey anti rabbit IgG Alexa 647 
Molecular Probes A-31573 IF 1:300 
Secondary antibody anti rabbit with 
Alexa 647 label 
Donkey anti mouse IgG Alexa 488 
Molecular Probes A-21202 IF 1:500 
Secondary antibody anti mouse 
with Alexa 488 label 
Donkey anti mouse IgG Alexa 594 
Molecular Probes A-21203 IF 1:1000 
Secondary antibody anti mouse 
with Alexa 594 label 
Donkey anti mouse IgG Alexa 647 
Molecular Probes A-31571 IF 1:300 
Secondary antibody anti mouse 
with Alexa 647 label 
Goaf anti chicken IgY –CF488A 
Sigma SAB4600039 IF 1:1000 
Secondary antibody anti chicken 
with CF488A label 
 





2.2: Cell Biology  
 
2.2.1: CEF harvesting and maintenance 
Chicken embryo fibroblasts (CEFs) were obtained from 10-day old chicken 
embryos (Gallus gallus domesticus, Bovans Brown, Henry Stewart and Co. 
Ltd) according to a standardized protocol (Lam, 1995). Ethics was obtained by 
Animal Welfare and Ethical Review Body (AWERB) and project reference is 
29/15-16. Eggs were kept at 37 ºC at 80 % humidity until day 10 after 
fertilization.  Briefly, 10-day old fertilised chicken eggs were opened, embryos 
decapitated and separated from the yolk. Embryo bodies were then cut into 
small pieces using scissors, washed in warm PBS and covered with 0.025% 
trypsin-EDTA (Sigma) for 2 minutes at room temperature (RT). Supernatant 
was transferred into 10 volumes of FBS. The digestion process was repeated 
four times, each time covering the embryo pieces with trypsin. The cells were 
pelleted out of FBS by centrifugation at 500 xg for 5 minutes and re-suspended 
in complete CEF media (1x Medium 199 (Sigma), 10% Tryptose phosphate 
broth (Sigma), 2.3 g/l sodium bicarbonate (Sigma), 1 mM L-Glutamine 
(Sigma), 100 U/ml penicillin and streptomycin (Sigma) and 10% FBS (Sigma)). 
The cells were subsequently passed through a 40µm filter to remove any large 
clumps. The cells were then pelleted by centrifugation at 500 xg for 5 minutes 
and re-suspended in freezing media (90% FBS + 10% DMSO (99.9%)). 
Aliquots were frozen using Mr. Frosty freezing containers cooling at 1 ºC/min 
until -80 ºC and stored in liquid nitrogen.   
 
For routine cell culture, a frozen aliquot of CEFs was thawed at 37 ºC and 
transferred to 5ml CEF media. The CEF were spun briefly at 500 xg, and the 
pellet was re-suspended in pre-warmed 5 ml CEF media and transferred to a 
T25 flask. The cells were incubated in a humidified incubator at 38.5 ºC and 
5% CO2. During cell passaging, CEFs were first washed with PBS once and 
subsequently treated with 0.025% trypsin-EDTA (Sigma) for 3-5 minutes at 
38.5 ºC. Detached cells were then re-suspended in CEF media to inhibit the 
trypsin-EDTA, and transferred to a new T25 flask at a 1:2 ratio split. The 
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number of splits per batch of frozen cells was kept to a maximum of 4 
passages 
 
2.2.2: Other cell line maintenance 
Prof. Venugopal Nair's group kindly provided DF-1 cells, these are an 
immortalised chicken fibroblast cell line. Frozen aliquots of passage 10 DF-1 
cells were thawed in DF-1 complete media (High Glucose (4500ml/l) DMEM 
(D6429, Sigma) supplemented with 10% FBS and 100U/ml penicillin and 
streptomycin (Sigma)) and transferred to T25 flasks. The cells were incubated 
in a humidified incubator at 38.5 ºC and 5% CO2. During cell passaging, DF-1 
cells were first washed with PBS once and subsequently treated with 0.025% 
trypsin-EDTA (Sigma) for 3-5 minutes at 38.5 ºC. Detached cells were then re-
suspended in DF-1 media to inhibit the trypsin-EDTA, and transferred to a new 
T25 flask at a 1:10 ratio split. The number of splits was kept to a maximum of 
10 passages after thawing cells. 
 
2.2.3: Transfections 
Transfection of expression plasmids into cells was carried out with FuGENE-
6 transfection reagent (Promega). Briefly: 1-2ug of plasmid DNA was added 
into 50µl of OptiMEM (Sigma) medium. This mixture was vortexed for 5 
seconds, and 4.5 µl/per µg of DNA of FuGENE 6 transfection reagent was 
added. The transfection solution was mixed by pipetting for 1min. The mixture 
was incubated at RT for 15 minutes. Fresh media was added to dishes prior 
to drop-wise addition of the transfection mixture into each FluoroDish quadrant 
(FisherScientific). Transfected cells were at 80 % confluence.  More significant 
volumes of transfection were scaled up accordingly. In the case of multiple 
plasmid transfections; the plasmids were mixed well, before mixing with 






2.2.4: Establishment and maintenance of virus infection  
Viruses used in this study:  
 
RB1B UL35-GFP: Wild type strain of MDV that has had GFP fused to the small 
capsid protein UL35. This tag allowed visualisation of individual viral particles 
in the nucleus and the cytoplasm. The GFP tag resulted in attenuation of 
infection and the virus spread 50% slower than the parental virus used to 
generate tagged virus in a cell monolayer (Kut and Rasschaert, 2004). 
 
RB1B TK GFP: Wild type strain of MDV that expresses GFP from a TK 
promotor. This allowed visualisation of infected cells and to follow viral spread. 
No attenuation of virus spread was detected with this tag compared to the 
parental virus used to generate this fluorescent virus (Shimojima et al., 1997).  
 
RB1B EGFP-UL49: Wild type strain of MDV that expresses EGFP tag on the 
N-terminal of UL49 gene product. This tag allowed visualisation of UL49 
protein in an MDV infected cell. This virus has attenuated viral spread in a 
monolayer at 60% compared to the parental virus (Remy et al., 2013).  
 
CEF cells were transfected with BAC DNA of RB1B UL35-GFP (kindly 
provided by V. Nair’s group) (Kut and Rasschaert, 2004) or RB1B TK GFP  
(Shimojima et al., 1997) (also kindly provided by V. Nair’s group) or RB1B 
EGFP UL49 (Remy et al., 2013) (kindly provided by C. Denesvre group) using 
Lipofectamine 2000. Briefly: Fresh CEFs were seeded into six-well plates 
when cells reached 80% confluence, 2 µg of BAC DNA was added to 180 µl 
of OptiMEM, mixed by very gently pipetting then 20 µl of Lipofectamine 2000 
was added to the mixture. The transfection solution was mixed by inversion 
and incubated for 20 minutes at RT. 800 µl of OptiMEM was added to the 
mixture. 1ml of transfection mix was added to CEFs by completely replacing 
media. The cells were then returned to the incubator. The transfection mixture 
was replaced with 2 ml complete CEF media after 6 hours.  
 
Once transfection had occurred, the virus infection spread in the CEF 
monolayer. Maximal infection is usually reached after 5-6 passages – fresh 
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CEFs are added after three passages. After infection reaches around 30-50%, 
the cells are frozen in freezing media (90% FBS and 10% DMSO) and stored 
at -80ºC. Plaque forming units/ml (PFU/ml) were calculated from each 
harvested batch using plaque assays. Here, infected cells were thawed, 
diluted and seeded onto a monolayer of uninfected CEFs. The new infection 
was initiated by co-culturing with uninfected CEFs. The number of plaques per 
well were counted. Infection was maintained by passaging infected CEFs onto 
new CEFs for a maximum of 10 passages. 
 
2.2.5: Immunofluorescence staining   
CEFs or infected CEFs were seeded onto 16mm round coverslips at 10,000 
cells per coverslip. Once cells adhered, incubated for 12 hours, they were fixed 
using Fixation buffer (4% Paraformaldehyde (PFA) (Electron Microscopy 
Sciences), and 0.1% Glutaraldehyde (GA) (Electron Microscopy Sciences) in 
MRB80 (80mM PIPES pH 6.9, 1mM EGTA, 4mM MgCl) and adjusted to pH 
7.5) for 10 minutes. PFA and GA were then reduced with 0.1% NaBH4 for 7 
minutes. Cells were blocked and permeabilised with 3% BSA and 0.2 % Triton 
X100 (Sigma) in PBS at room temperature (RT) for 1 hour prior to incubation 
with primary antibodies/cell stains (e.g., DM1A (1:1000) or 647-phalloidin 
(1:1000)) for 1 hour in 3% BSA (Sigma) and 0.2 % Triton X100 in PBS in a 
humidified chamber. Cells were washed 1x in 0.3% BSA, 0.02% Triton X100, 
followed by 2x PBS, prior to incubation with the appropriate species-specific 
secondary antibodies (anti-mouse Alexa 561 (1:500) for DM1A). Coverslips 
were washed with PBS and stained with DAPI (0.1 µg/ml) for 1 minute. The 
coverslips were washed with PBS x3 and mounted onto glass slides using 
Vectashield (H-1000) and sealed with nail varnish. Slides were visualised 
using a spinning disk confocal system (Ultraview Vox, Perkin Elmer) with a 
100x 1.4 NA oil-immersion objective.  
 
Cells were fixed with methanol by removing media on cells and replacing with 
ice-cold methanol and placed in -20ºC for 1 hour. Methanol fixed cells were 
prepared for immunoflouresence by removing the methanol from the wells and 
washing with PBS at RT 3x, 5 minutes each. The cells were then blocked right 
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away using with 3% BSA in PBS for 1 hour at RT. Cells were then incubated 
with primary antibodies/cell stains (e.g. DM1A (1:1000) or 647-phalloidin 
(1:1000)) for 1 hour in 0.3% BSA (Sigma) in PBS in a humidified chamber. 
Cells were washed with PBS 3x 5 minutes at RT, prior to incubation with the 
appropriate species-specific secondary antibodies (i.e. anti-mouse Alexa 561 
(1:500) for DM1A) for 1 hour. The coverslips were washed with PBS x3 and 
mounted onto glass slides using Vectashield (H-1000) and sealed with nail 
varnish. Slides were visualised using a spinning disk confocal system 
(Ultraview Vox, Perkin Elmer) with a 100x 1.4 NA oil-immersion objective.  
 
2.2.6: Plaque Assays 
Confluent CEFs were infected with 100 plaque forming units (PFU) of RB1B 
TK GFP. Twenty-four hours post infection each well was treated with varying 
concentrations of either, Nocodazole, Cytochalasin D, Taxol or DMSO. 48 
hours post infection the dishes were imaged live using an Olympus IX71 
inverted fluorescence microscope with Deltavision system (Applied Precision 
LLC) in a stage-top incubator (Tokai Hit) at 37 ºC and 5% CO2. The acquisition 
was controlled by Softworx (Applied Precision LLC) with 10x 0.40 NA air 
objective. The GFP channel was imaged for every plaque detected. The area 
of each plaque was measured manually using the free line tool in Fiji (Image 
J). Three independent replicates were carried out for each experiment with a 
minimum of 60 plaques analysed for each replicate. Statistical significance 
was determined using a one-way ANOVA.   
 
2.2.7: Cold treatment assay 
CEFs were seeded onto 16mm round coverslips in 12 well plates at 30-50% 
confluence and incubated in a humidified incubator at 38.5 ºC and 5% CO2. 
The next day, the plate was taken out of the incubator and directly placed on 
ice for 10 minutes, ensuring the plate was covered with ice. The media was 
then completely removed, and cells were fixed in -20ºC methanol for 1 hour. 
The coverslips in each well were then prepared for immunofluorescence (see 
immunofluorescence section for detailed protocol) with antibodies against α-
tubulin and acetylated α-tubulin. Slides were visualised using a spinning disk 
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confocal system (Ultraview Vox, Perkin Elmer) with a 100x 1.4 NA oil-
immersion objective. Complete cell Z-stacks were taken for 10 cells at each 
condition. Stacks were then Z projected using Fiji and mean intensity of 
microtubule density was measured in the cytoplasm. The experiment was 
repeated 3 times. Statistical significance was determined using a two-sample 
t-test. 
 
2.2.8: Viral capsid transport assay  
CEFs infected with RB1B UL35-GFP were seeded into fluorodishes (40,000 
cells per dish). After 24 hours, the cells were treated with 5 µM Nocodazole or 
500 pM Taxol or 100 µM Celiobrevin D or DMSO in imaging media (L-15 with 
5% FBS, 1 mM L-Glutamine (Sigma), and 100 U/ml penicillin and streptomycin 
(Sigma)) for 1 hour in a humidified incubator at 38.5 ºC and 5% CO2. Infected 
cells were imaged using a spinning disk confocal system at 37 ºC (Ultraview 
Vox, Perkin Elmer) with a 100 x1.4 NA oil-immersion objective, 3 x Z-stacks at 
0.75µm step size and at 2.6 frames per second (FPS) for 3 minutes using 488 
nm laser. Movies were then Z-projected using Fiji. Viral capsids were tracked 
semi-automatically using Image-Pro Analyzer. Viral capsid dynamics were 
determined by first tracking all viral capsids that were 5 µm away from the 
closest nucleus. The greatest distance each viral capsid travelled from its point 
of origin was then determined. If this was greater than 5 µm then that viral 
capsid was marked and shown as a ‘run’ suggesting active transport. Any viral 
capsid track lasting fewer than 100 frames was not considered for analysis. 
For all experiments 10 cells of each condition were tracked and every 
experiment was repeated 3 times. Statistical significance was determined 
using a two-sample t-test.  
 
2.2.9: Split-Kinesin Assay  
The plasmids pKif5C559-tdTM-FKBP and pFRB-3myc_KifXtail (Kif5C, Kif17, 
Kif1A, Kif1Ba, Kif1Bb, Kif13A, Kif13B and Kif21B) (detailed in table 5), 
provided by G. Banker’s Lab (Jenkins et al., 2012), were both transfected into 
CEFs using FuGENE6. Only a single kinesin tail construct was transfected 
along with the Kif5C plasmid. Therefore, there was be 8 kinesin tails 
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investigated during each experiment. Transfections were carried out in one 
quadrant of a fluorodish that has been separated into four quadrants (Fisher 
Scientific).  The negative controls for this experiment were CEFs transfected 
with Kif5C motor domain plasmid only, and cells that had not undergone any 
transfection.  Transfected cells were subsequently infected with RB1B UL35-
GFP virus by co-culturing with infected CEFs. Two days post-transfection a 
small population of transfected cells would also be infected with RB1B UL35 
GFP virus (0.5-1%). A single cell was imaged per quadrant. Using the spinning 
disk microscope, transfected and infected cells were selected and imaged with 
3 x Z planes at 0.75µm step size at 2.6 FPS for 1 minute using a 488nm laser 
at 5% power. A 561nm image was taken to confirm transfection. Rapamycin 
(2nM final concentration) was then added, and after 10 minutes the same cell 
was imaged again using the same imaging conditions. Movies were then Z-
projected using Fiji. Viral capsids were semi-automatically tracked using 
Image-Pro Analyzer. The greatest distance each viral capsid has travelled 
from its point of origin was then determined. If this was greater than 1.5 µm 
then that viral capsid was marked and shown as a ‘run’ suggesting active 
transport. Any viral capsid track lasting fewer than 50 frames was not 
considered for analysis. For all conditions between 4-10 cells were tracked. 
Statistical significance was determined using a paired t-test.  
 
2.2.10: shRNA mediated depletion  
The plasmids pSuper-CherryTub-shRNAKifX (Kif21B, Kif13B Kif13A, 
Kif13A/B and Kif1B) were each transfected individually into RB1B UL35-GFP 
infected CEFs using FuGENE6 according to the manufacturer’s instructions 
and as described above. The transfected cells were subsequently infected by 
co-culturing with RB1B UL35-GFP infected CEFs. Two-days post transfection, 
cells that were both transfected and infected were selected and imaged with 3 
x Z planes at 0.75µm step size at 2.6 FPS for 3 minutes using 488nm laser at 
5%. A 561nm image was taken to confirm transfection. Movies were then Z-
projected using Fiji. Viral capsids were semi-automatically tracked using 
Image-Pro Analyzer. The greatest distance each viral capsid has travelled 
from its point of origin was then determined. If this was greater than 3 µm then 
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that viral capsid was marked and shown as a ‘run’ suggesting directional 
movement. Any viral capsid track lasting fewer than 100 frames was not 
considered for analysis. For all conditions 6 cells were tracked at least per 
experiment and experiments were repeated 3 times independently. Statistical 
significance was determined using a two-sample t-test.  
 
2.2.11: Cell Shape assay using Shape Space Explorer  
CEFs infected with RB1B TK GFP virus were seeded at low density (10,000 
cells) into fluorodishes. These cells were either treated with DMSO or 500 pM 
Taxol. Low-density seeding ensured that single cells could be imaged for a 
long time without interference from neighbouring cells and sequential cell 
shapes were obtained. Cells were imaged live using an Olympus IX71 inverted 
fluorescence microscope with Deltavsion system (Applied Precision LLC) in a 
stage-top incubator (Tokai Hit) at 37 ºC and 5% CO2. A 20x air objective with 
0.75 NA was used. The acquisition was controlled by Softworx (Applied 
Precision LLC) at 10 min/frame for 24 hours. GFP and bright-field images were 
taken. The GFP signal was used to confirm infected cells, and bright-field 
images were used to manually draw around each cell using the polygon tool 
in Fiji. For each cell at every time point in a sequential manner the cell shape 
was extracted until it was not possible to define cell shape due to interference 
from other cells or 20 time points had been reached. Using a custom macro 
each cell shape was saved. The saved cell shapes were then used in Shape 
Space Explorer (Jefferyes and Straube, unpublished) to visualise and quantify 
the morphology of cells in the data set. Ten cells per condition per experiment 
were analysed. Experiments were repeated 3 times independently.   
 
 
2.2.12: STORM  
CEFs were prepared for Stochastic optical reconstruction microscopy 
(STORM) by fixation in 4% PFA, 0.1% GA in MRB80 pH 7.5 for 10 minutes. 
PFA and GA were then reduced with 0.1% NaBH4 for 7 minutes, and washed 
thrice with PBS (5 minutes each). Cells were then blocked and permeabilised 
with 3% BSA and 0.2 % Triton X100 in PBS pH 7.5 at RT for 1 hour. 
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Immediately after blocking, cells were incubated in primary antibody DM1A 
(1:1000 in 3% BSA and 0.2% Triton X100 in PBS (p.H 7) in a humidified 
chamber for 1 hour. Cells were washed 3x 5 minutes with PBS. The secondary 
antibody used was anti-mouse Alexa 647 (1:1000).  Cells were incubated in 
secondary antibody diluted in 3% BSA and 0.2% Triton X100 in PBS pH 7 in 
a humidified chamber for 50 minutes. Cells were washed thrice in PBS (10 
minutes each). Cells and antibodies were post-fixed using 4% PFA, 0.1% GA, 
MRB80 pH 7.5 for 5 minutes. After post-fixing, cells were washed 3x 5 minutes 
in PBS. PBS was replaced with STORM/OxEA buffer (Nahidiazar et al., 2016) 
(50 mM β-mercaptoethylamine hydrochloride (MEA, Sigma-Aldrich), 3% (v/v) 
OxyFlour (Oxyrase Inc.) and 20% (v/v) sodium DL-lactate solution (L1375, 
Sigma-Aldrich) in PBS, pH 8–8.5) prior to imaging.  
 
STORM images were acquired using the Warwick Open Source Microscope 
(WOSM) TIRF system using an oil-immersion 100x 1.46 NA objective. 20,000 
frames at 10ms exposure were acquired with 40-60 kW/cm2 647 nm laser 
power in combination with 1-5 kW/cm2 of 405 nm laser. The sample was 
bleached with 100 kW/cm2 laser power for 30s before acquisition. 
Reconstruction was performed using the Image J plugin ThunderSTORM 
(Ovesny et al., 2014). The parameters used were as follows: Image filtering: 
Wavelet filter (B Spline), Approximate localization at local maximum with 
3*std(Wave.F1), Sub pixel localization at PSF: Integrated Gaussian with 3 
pixel fitting radius and visualisation with average shifted histograms and 5x 
magnification. Further post processing was carried out after image generation, 
this were removing uncertainty (nm) values over 10, removing duplicates 
based on uncertainty values and correcting for drift based on cross correlation.  
 
STORM staining using microfluidics was carried out by a simple microfluidics 
system that involved; a 2ml syringe connected to 10 cm long 0.1 mm thick 
tubing that lead to the chamber where the cells were growing. On the other 
side of the chamber was the output tubing that lead to a waste beaker. Flow 
was controlled using gravity. Chambers were made using PDMS 184 
(Scientific laboratory Supplies). Chamber designs were cut from double sided 
tape using an electronic cutting tool (Silhouette Portrait). The positive chamber 
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designs were attached to the bottom of a 10cm petri dish and PDMS was 
poured to over to cover the moulds. PDMS was then de-gassed and baked at 
60 ºC over night. Each chamber design was carefully removed from the mould 
to reveal a chamber underneath. The PDMS was then bound to a 50 mm x 24 
mm glass coverslip using a bench top plasma generator (Henniker Plasma) 
for 3 minutes at 40W to charge the glass. The cut PDMS was then bound to 
the cover slip creating a chip. Input and output openings were created using a 
needle and tubing was inserted. CEFs were then seeded into the chamber 
with gravity flow and treated the same way as described above.  
 
During this experiment, the viral capsids were imaged live for 1 minute in the 
chamber using the TIRF capabilities of the WOSM, and then cells would be 
fixed by flowing fixation buffer into the chamber. The fixed cells in the viewing 
chamber would then be stained for STORM by flowing in the buffers and then 
same cell imaged live previously would be processed for STORM imaging. By 
performing live imaging of viral capsids and the STORM imaging of the same 
cell on the same microscope mean no correlation between the two images 
was be required. 
 
Correlative spinning disk confocal microscopy and STORM were carried out 
by using a girded glass bottom dish (MatTek), the infected cells were imaged 
live for 30s using a spinning disk microscope (Ultraview Vox, Perkin Elmer) 
with a 100x 1.4 NA oil-immersion objective and an environmental chamber.  
The cells were then fixed on the microscope stage using 2x fixing buffer to 
compensate for the media already in the dish during imaging. Imaging 
continued until all viral capsids stopped moving. The cells were then 
processed for STORM staining in the dishes, and the same cell was 
subsequently found again using the coordinates etched on to the dish on the 
WOSM. The cell was imaged using the WOSM with TIRF settings for viral 
capsids and microtubules. Then the STORM procedure was carried out. The 
two separate images were then correlated back together using the final frame 
of the dynamic viral capsid movie from the confocal and static viral capsid 
image from the WOSM. Correlation in X and Y, was achieved by using ICY 
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(image analysis software) and a plugin called eC-CLEM (Paul-Gilloteaux et 
al., 2017). 
 
2.2.13: SRRF Microscopy   
Super-resolution radial fluctuations (SRRF) images were obtained using an 
Inverted Marianas Microscope (3i, Denver, USA) with CSU-X1 spinning disk 
confocal (Yokogawa, Japan) and a sCMOS 95B Prime Camera (Photometrics) 
with a 100x 1.46 NA oil-immersion objective (Zeiss, Jena, Germany). Encased 
in a 37ºC degree incubator (Okolab, Italy). The acquisition was controlled by 
Slidebook 6.0 software (3i) using stream mode. CEFs cells infected with RB1B 
UL35-GFP were seeded onto fluorodishes. Prior to imaging, CEF media was 
replaced with SRRF imaging media (L-15, 5% FBS, P/S, L-Glut, 1% Oxyrase, 
1 µM Verapamil) and treated with 1 µM SiR-tubulin dye (Lukinavicius et al., 
2013) for 1 hour. Images were collected by direct streaming to the hard-drive 
to obtain 50 FPS acquisition rates using 647nm laser line with a single frame 
of 488nm every 50 647nm frames. Using the NanoJ-SRRF plugin (Gustafsson 
et al., 2016) in Fiji, movies of super-resolution microtubules were constructed 
at 1 FPS, and this was correlated with the 488 nm capsid image.  
 
Viral capsid event occurrence was determined using the SRRF movies. These 
were scored with a 0 for absence or 1 for the presence for 9 different events. 
Three different categories describe capsids that are not associated with 
microtubules and are: (i) stationary (>500 nm), (ii) diffusing far from 
microtubule (>500 nm), and (iii) diffusing near microtubule (<500 nm) but 
appear to ignore the microtubule. The other 6 categories describe different 
types of association of viral capsids with microtubules: (iv) Diffusing near 
microtubule (<500 nm) and occasionally binding, (v) viral capsid switching 
tracks, (vi) viral capsid diffusing along a microtubule, (vii) viral capsid bound to 
microtubule but stationary, (viii) viral capsid running along microtubule and (ix) 
viral capsid showing bi-directional movement along microtubule. A total of 19 
cells from 3 independent experiments and a total of 385 viral capsids were 
characterized. Mean and standard deviation of the percentages each event 
occurrence is presented.  
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2.2.14: Electron microscopy (EM) 
CEFs infected with RB1B UL35 GFP were seeded in to 6 well plates at full 
confluence and prepared for EM the following day. The rest of the protocol 
was carried out by Nick Clarke. CEFs were trysinised and all the cells were 
pooled together to form a single pellet by centrifugation at 300 xg for 2 minutes 
at RT. Cells were then re-suspended in cryoprotectant (DMEM with 10% FBS, 
and 10% BSA). Cells were loaded into an aluminium type B carrier (approx. 1-
2 ul). A second type B carrier was placed, flat side down, on top of the cells 
and then immediately frozen in the HPM100 High Pressure Freezer. Frozen 
carriers were transferred to the AFS2 (Low temperature resin embedding 
system), pre-cooled to -130 °C, and cells were embedded in resin (HM20). 
This was carried out by placing cells into a flow through chamber (cell side 
up). Cooled freeze substitution (FS) media (2% Uranyl acetate (UA), 5% dH2O 
in acetone) was added to each chamber (UA diluted from a 10% stock in 






Time Reagent UV 
Freeze 
substitution 
1 -130 -90 02:00 FS media 
 
 
2 -90 -90 06:00 FS media 
 
 
3 -90 -45 09:00 FS media 
 
 
4 -45 -45 03:00 FS media 
 
Wash 5 -45 -45 01:00 Acetone (x4 
wash) 
 












9 -45 -45 ON 100% HM20 
 
 10 -45 -45 02:00 100% HM20  
 11 -45 -45 02:00 100% HM20  
 12 -45 -45 02:00 100% HM20  
 13 -45 -45 02:00 100% HM20  
Polymerization 14 -45 -45 48:00 100% HM20 x 
 15 -45 25 16:00   
Table 8: Resin embedding programme 
Polyermized blocks were removed from the flow through chamber and the 
aluminium carrier was removed using a razor blade to expose the resin-
embedded cell pellet.  Sections of 200 nm were collected on (0.3%) formvar 
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coated finder grids. Sections were imaged on the Jeol 2100Plus this is a 200kV 
LaB6 instrument fitted with a Gatan OneView IS camera. Infected cells were 
found by scanning at low magnification. Cell infection was confirmed by 
looking for viral particles inside the nucleus. All found viral capsids in the 
cytoplasm was imaged at high magnification. Analysis was carried out by first 
determining if viral capsid had a viral membrane and if it was in a vesicle. Next 
all the microtubules in each image was determined and the distance of each 
viral particle to the closest microtubule (edge to edge) was measured using 
the line tool in Fiji. As a control, each image containing a viral capsid was split 
into even quadrants. Each viral capsid in the quadrant was shifted 200nm 
towards the opposite quadrant in a diagonal manner. In the new location 
distance to the nearest microtubule was measured again. This experiment was 
only carried out once. Statistical significance was determined using a 
Kolmogorov-Smirnov test.
 
2.2.15: Statistics  
One-way analysis of variance (ANOVA) was used to determine statistical 
significance in the viral plaque assays. LSD post-hoc test was used with 
comparing 3 means or below and Turkey’s HSD was used to compare 4 or 
more means. Statistical significance is shown above all conditions on relevant 
figures using asterisks (*= p<0.05 ** = p<0.005 *** = p<0.0005 ****=p<.00005). 
Two-sample T-test was used when comparing only two conditions (e.g., cold 
treatment assays). Samples were first checked for normal distribution using F-
test. If unequal distribution was suggested from the F-test then a Mann–
Whitney U test was carried out.  Paired T-test was used for the split kinesin 
assay analysis. Both populations were tested for distribution and T-test was 
adjusted according to F-test results to take in to account normal distribution in 
the two populations. Kolmogorov-Smirnov test was used to determine 
differences in distribution between large populations (e.g., viral capsid speeds 
with and without nocodazole). All statistical analysis was carried out on 
GraphPad Prism 8. 
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Chapter 3: MDV infection requires the host 
cytoskeleton 
 
Schumacher et al. (2005) suggested that microtubules are dispensable for the 
viral spread of MDV and that actin filaments are essential. This is surprising 
given that many Alphaherpesviruses depend on active transport along 
microtubules to move within the cytoplasm of the host cell (Mabit et al., 2002, 
Marozin et al., 2004, Topp et al., 1994). To determine the requirement of the 
cytoskeletal elements; actin and microtubules during MDV infection, the 
effects of cytoskeletal depolymerising drugs on viral spread were investigated.  
 
3.1: Cytoskeleton depolymerising/stabilising small agents effect 
efficiency of MDV viral spread 
 
To determine the requirement of microtubules and actin, the two main 
components of the cellular cytoskeleton, for the viral life cycle, a modified 
plaque assay was designed. Plaque assays are used for determining the 
concentrations of viral particles harvested from previously infected cells (Baer 
and Kehn-Hall, 2014). By modifying the classical plaque assay, it is possible 
to determine the effects that various drugs/small molecules might have on viral 
spread in a cell monolayer. Plaque assays represent viral spread in a 
monolayer. Any condition that effects viral spread can be seen as a smaller or 
larger viral plaque phenotype. Any defects induced from treatment to the viral 
cycle or replication defects and to structural defects can be monitored and viral 
plaque size is only and output of the assay. Briefly, the modified plaque assay 
involved seeding a monolayer of CEFs prior to infection with MDV RB1B virus 
that expresses cytoplasmic GFP under the control of the thymidine kinase (TK) 
promoter. Infection was allowed to establish for 24 hours and then was treated 
with various cytoskeleton modifying drugs for 48 hours. Each plaque from 
every condition was imaged at the end of the 48 hours. It is difficult to get a 
synchronised infection with MDV as it does not produce any cell-free viral 
particles and infection is started with infected cells. This means that a mixture 
of infected cells at different stages of infection are used for these experiments. 
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RB1B TK GFP virus compared to the parental wild type virus showed no 
change to viral kinetics in a plaque assay (Shimojima et al., 1997). Therefore, 
this fluorescent virus was used to track viral spread in these plaque assays. 
 
Nocodazole, which is a microtubule depolymerising agent (Lee et al., 1980), 
was used to determine the requirement of microtubules during the viral life 
cycle. Taxol, which is a microtubule stabilising drug (Wani et al., 1971, 
Weaver, 2014), was used to determine the requirement of microtubule 
dynamics during the viral life cycle. Cytochalasin D (CytoD) is a drug known 
to depolymerise actin filaments (Goddette and Frieden, 1986). This drug was 
used to determine the necessity of actin filaments to the viral life cycle. 
Concentrations of the small molecule inhibitors used in this study was based 
on the literature showing the same small molecule inhibitors used in the same 
cell types. No toxicity of these small molecule inhibitors was tested on the 
CEFs used here. The small molecule inhibitors and the concentrations used 
are well established in the literature (Richerioux et al., 2012, Schumacher et 
al., 2005). 
 
Treatment of CEFs with nocodazole had drastic effects on the size of viral 
plaques (Fig 3.1). Two different concentrations of nocodazole were used: 5 
µM nocodazole, a 70% reduction in viral plaque size can be observed, and a 
50% reduction at 0.5 µM suggesting a dose-dependent effect (Fig 3.1C). The 
use of nocodazole efficiently removes microtubules but does not remove actin 
(Fig 3.1B). This suggests that microtubules are required for efficient viral 
spread during the MDV life cycle in contrast to published findings 
(Schumacher et al., 2005). 
 
Treatment of a CEF monolayer with Taxol had a dose-dependent effect on the 
size of viral plaques (Fig 3.2). Four different concentrations of Taxol were 
used, and the highest concentration of 5 µM reduced average plaque size by 
75% (Fig 3.2A, C). This concentration of Taxol resulted in re-organisation of 
the microtubule network to form large bundles (Fig 3.2B, D).  At 0.5 nM the 
microtubule network appeared unaltered compared to DMSO-treated cells, 
however there was still a 40% reduction in viral plaque size (Fig 3.2C). These 
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findings suggest that dynamic microtubules are required for efficient viral 
spread.     
 
Treatment of CEFs with CytoD had potent effects on reducing the size of viral 
plaques (Fig 3.3). Two different concentrations of CytoD were used, 0.5 µM of 
CytoD caused a 90% reduction in viral plaque size. 0.05 µM CytoD resulted in 
10% reduction suggesting a dose-dependent effect (Fig 3.3C). The use of 
CytoD did not affect microtubules but efficiently removed actin bundles (Fig 
3.3B). This effect suggests that actin bundles are required for efficient viral 
spread during the MDV life cycle and are in line with previous findings 



























Figure 3.1: Effects of nocodazole on viral plaque size. 
(A) Representative images of plaques of MDV infected CEFs treated with different 
concentrations of nocodazole (Noc). GFP highlights infected cells. The red outline 
indicates the boundaries of each viral plaque. Scale bar is 200 µm (B) CEFs treated with 
nocodazole and stained with DAPI and anti-α-tubulin antibodies or phalloidin-561 to 
visualise the effects of nocodazole on the cytoskeleton. Scale bar is 20 µm. (C) Graph 
showing plaque areas pooled from three independent experiments (n=180-240 plaques 
for each condition). Red line indicates the mean of the data. Statistical significance **** 
p=<0.0001 (LSD post-hoc test).  
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Figure 3.2: Effects of Taxol on viral plaque size. 
(A) Representative images of plaques of MDV infected CEFs treated with different 
concentrations of Taxol. GFP highlights infected cells. The red outline indicates the 
boundaries of each viral plaque. Scale bar is 400 µm. (B) CEFs treated with Taxol and stained 
with DAPI as well as anti-α-tubulin antibodies to visualise the effects of Taxol on the 
cytoskeleton. Scale bar is 20 µm (C) Graph showing plaque areas pooled from three 
independent experiments (n=100-120 for each condition). Red line indicates the mean of the 
data. Statistical significance *** p =0.0001, **** p =< 0.0001 (Turkey’s HSD post-hoc test). (D) 
The graph is showing data of mean intensities of α-tubulin staining taxol-treated cells (n=>20). 
A red line indicates the average. Statistical significance *** p =0.0001, n.s. = not significant 





Figure 3.3: Effects of Cytochalasin D on viral plaque size. 
(A) Representative images of plaques of MDV infected CEFs treated with Cytochalasin D. 
GFP highlight infected cells. The red outline indicates the boundaries of each viral plaque. 
Scale bar is 200 µm. (B) CEFs treated with Cytochalasin D and stained with DAPI as well as 
anti-α-tubulin antibodies or phalloidin-561 to visualise the effects of Cytochalasin D on the 
cytoskeleton. Scale bar is 20 µm (C) Graph showing plaque areas pooled from three 
independent experiments (n=150-200 for each condition). Red line indicates the mean of the 
data. Statistical significance **** p =< 0.0001 (LSD post-hoc test). 
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3.2: Dynamic microtubules are required for cell shape changes 
induced during MDV infection. 
 
Both, depolymerisation as well as stabilization of the microtubule network had 
drastic effects on viral plaque size. As MDV is a strictly cell-associated virus 
(Ahmed and Schidlovsky, 1968, Churchill and Biggs, 1967, Solomon et al., 
1968), the infected cell needs to make direct contact with target cells in order 
for intracellular viral spread to occur. An important observation made when 
investigating the cytoskeletal arrangement of MDV infected cells was the 
appearance of extended protrusions that form from infected cells towards 
uninfected cells when sparsely seeded in culture. This observation was 
brought to attention by Prof. Nair’s group initially (unpublished). Other 
Alphaherpesviruses have been reported to induce cytoskeletal 
rearrangements and cell extensions during the late stages of infection (Dixit et 
al., 2008, Favoreel et al., 2005, Oh et al., 2010).  
 
This observation prompted the investigation of the role of microtubules on 
infection-induced cell shape changes. To facilitate this, a custom MatLab 
package developed in Straube Lab called Shape Space Explorer 
(unpublished) was used. This script can analyse manually drawn or auto-
detected shapes within a data set and represent these in a 2D shape space 
based on their morphology. Therefore, the closest shapes in shape space will 
be very similar to each other and the further away the shapes are the more 
different they are.   
 
Based on the exemplar shapes observed and plotted (Fig 3.4A), a wide range 
of shapes were detected within our data set from: almost perfectly round cells 
to elongated cells and to ‘irregularly shaped’ cells with multiple protrusions. 
For visualisation purposes of the entire shape space, each shape is 
represented as a location in shape space. Infected CEFs and CEFs occupy 
different locations in shape space (Fig 3.4B). Treating these cells with 500 pM 
Taxol results in further separation from the untreated cells in shape space. 
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This suggests that infected cells produce different shapes compared to 
uninfected CEFs. Taxol treatment also results in cellular cell shape changes.  
 
To be able to quantify these observed differences, a shape space area 
analysis was performed. Based on the types of shapes in the shape space the 
data was divided into four distinct regions. Each cluster represents a general 
shape. Region 1 represents elongated shapes, region 2 round shapes, region 
3 are slightly elongated with single protrusions and region 4 containing 
irregular shapes with multiple protrusions (Fig 3.5A). 
 
When the fraction of shapes in each region is plotted for each condition 
significant differences in cell shape can be observed (Fig 3.5B). CEFs 
predominantly have slightly elongated shapes with single protrusions. When 
treated with 500 pM Taxol this shifts to many more elongated cellular shapes. 
MDV-infected CEFs mainly showed cell shapes with multiple protrusions. 
When infected cells were Taxol-treated, these became predominantly round. 
These data suggest that the loss of dynamic microtubules during infection 
results in a loss of cytoskeletal changes induced during MDV infection. 
Dynamic microtubules are also required for required for intracellular viral 









Figure 3.4: Shape Space Explorer: exemplary shapes and diffusion map slicing. 
(A) Exemplar shapes in shape space. This plot shows the first two coordinates in the 
diffusion map embedding (B) Shape space showing locations of all shapes recorded in 
each condition – CEFs, CEFs infected with RB1B TK GFP and Taxol treated infected and 
uninfected cells. In blue is the average cell shape in each slice of shape space for co-
ordinate 1. In green is the average cell shape in each slice of shape space for co-ordinate 




Figure 3.5: Shape Space Explorer: Area analysis. 
(A) Area analysis in shape space. The shape space is separated into four distinct regions. 
(B) Bar charts show the percentage of shapes located within each region. Below are 
representative images to highlight the typical cell shape in each region. N=10 cells per 
experiment, repeated 3 times. 
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3.3: MDV infection does not result in changes to the post-
translational modifications of microtubules  
 
Results from the cell shape analysis and plaque assays suggested that 
microtubules are required during MDV infection. The microtubule network may 
be targeted during the MDV infection (O'Donnell et al., 2002). There is a 
possibility that MDV infection may stabilize microtubules to provide a transport 
network for viral capsids during egress. HSV-1 and another Alphaherpesvirus 
have been shown to stabilize microtubules through various viral proteins like 
US3 that interacts with CLASPs (Naghavi and Walsh, 2017), VP22 that directly 
binds microtubules (Elliott and O'Hare, 1998) and UL37 that interacts with 
dystonin (Pasdeloup et al., 2013b). 
 
Post translational tubulin modifications like acetylated tubulin provide a marker 
to identify highly stable microtubules (Perdiz et al., 2011, Takemura et al., 
1992). Highly stable microtubules will in turn be used preferentially by some 
molecular motors for vesicle trafficking (Janke and Bulinski, 2011, Naghavi 
and Walsh, 2017). For example, kinesin-1s use poly-glutamylated 
microtubules while kinesin-2s prefer detyrosinated microtubules (Sirajuddin et 
al., 2014). Investigating any changes that occur to PTM’s of tubulin can provide 
insights into how viral capsids are transported during infection and if the virus 
modifies microtubules.  
 
Immunofluorescence allowed visualization of the microtubule network, 
specifically, tubulin post-translational modifications, in CEFs and MDV-
infected CEFs. CEFs were infected with a virus that expresses a GFP tagged 
UL49 protein. The reason for the change from using RB1B TK GFP virus to 
RB1B UL49 EGFP virus is that when RB1B TK GFP virus is fixed using 
methanol the cytoplasmic GFP is washed away making it difficult to determine 
infected cells when imaging. UL49 EGFP remains visible with methanol 
fixation. Therefore, this virus was used to identify infected cells when 
screening for infection and any changes to the microtubule network. 
Acetylated tubulin, polyglutamate modifications and longer polyglutamate 
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chains were analysed. No visual change in each of the modifications 
investigated was observed between uninfected CEFs and CEFs infected with 
RB1B UL49 EGFP (Fig 3.6A).  
 
The levels of each protein were also analysed by Western blotting. CEFs 
infected with RB1B TK GFP or uninfected CEFs were investigated and were 
harvested for whole cell lysate. Acetylated tubulin, polyglutamate chains and 
α-tubulin were detected using specific antibodies. Based on the levels from 
the western blots, no change in the levels of microtubule modifications was 
observed (Fig 3.6B).  A draw back with this experiment is that a control band 
for infection, such as a specific viral protein, is not present making it hard to 
determine if infection was present. However, before lysing the cells the dishes 
were checked for infection using a widefield microscope and infection was at 
45 % before lysis. Therefore, both approaches suggest that any changes 
induced to the microtubule network during MDV infection do not result in 
changes to post-translational modifications like acetylation and polyglutamate 















Figure 3.6: Post-translational modifications of microtubules during MDV infection. 
(A) Immunofluorescence images show acetylated tubulin, polyglutamate modifications and 
polyglutamate chains on microtubules in grey. These were detected using antibodies specific 
to each modification. CEFs infected with RB1B EGFP UL49 are in green. Merge of all 
channels together is also shown, green is UL49 GFP and red is each modification. Scale bar 
is 20 µm. N= 3 independent experiments (B) Western blot showing levels of α-tubulin, 
acetylated tubulin or polyglutamate chains on microtubules from whole cell protein extracts. 
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3.4: CEFs have highly stable microtubules. 
 
Analysis of microtubule modifications revealed that CEFs have a high number 
of acetylated microtubules (Fig 6A). Acetylation of tubulin is thought to indicate 
increased stability of microtubules (Takemura et al., 1992), suggesting that 
microtubules in CEFs could be highly stable. To test this, a cold treatment 
assay was employed. This assay is generally used in the mitosis community 
to remove unstable microtubules outside of k-fibers (DeLuca et al., 2006). 
Thus, in interphase CEFs, unstable microtubules introduced to low 
temperatures should largely depolymerise. CEFs were treated on ice for 20 
minutes and then fixed using methanol and processed for 
immunofluorescence probing for α-tubulin and acetylated tubulin.         
 
The dense microtubule network is obvious in CEFs. Many of the microtubules 
are heavily acetylated. When treated on ice the microtubule network is not 
affected (Fig 3.7A). When the density of microtubules is quantified before and 
after cold treatment, there seems to be a slight increase in mean intensity 
levels (Fig 3.7B).  There is no change in the intensity of microtubules that have 
been acetylated (Fig 3.7B). This observation suggests that cold treatment of 
CEFs does not depolymerise microtubules. This further implies that CEFs 
have a naturally stable pool of microtubules and, that the MDV infection may 













Figure 3.7: Microtubules in CEFs are highly stable. 
(A) Immunofluorescence images showing α-tubulin and acetylated tubulin in grey. Red box 
indicates area in insert. (B) The graphs show mean intensities of α-tubulin and acetylated 
tubulin staining (n=>30, 3 independent experiments). A red line indicates the average. 
Statistical significance * p= < 0.05, n.s not significant (two-sample t-test). 
 75 
3.5: Discussion  
 
3.5.1: Microtubules are essential for efficient MDV viral spread 
 
The finding that microtubules are essential to MDV viral spread contradict 
Schumacher et al. (2005), who suggest that microtubules are dispensable. 
Schumacher et al. (2005) used plaque assays to show that CytoD reduces 
plaque sizes significantly but nocodazole treatment does not.  There could be 
several reasons for the discrepancy with our results. The first reason could be 
that fact that using 5 µM nocodazole all microtubule structures were 
depolymerized in this study, however, the same concentration of nocodazole 
has clearly not depolymerized all microtubule structures in the 
immunofluorescence (IF) images presented by Schumacher et al. (2005). This 
suggests that microtubules are present during their plaque assay and could 
explain the lack of plaque size reduction compared to the control.  
 
Further reasons could be the differences in experimental design. For the 
plaque assays used during this study frozen infected cells were thawed 
directly on to the CEF monolayer. Nocodazole was introduced to the cells after 
infection was established, and no media was changed during the 48 hours of 
incubation with inhibitors. Schumacher et al. (2005) transfected the cell 
monolayer with BAC20 viral plasmid and then added drugs 8 hours after 
transfection. Fresh media with drugs was added every 12 hours for 5 days. 
With these differences, there could be a difference in the outcome of the 
experiment. Transfection versus seeding infected cells on to a confluent 
monolayer could result in different dynamics of viral spread. Seeding cells 
more closely represents physiological conditions when compared to 
transfections to start a viral spread assay. As an infecting viral particle brings 
in a tegument layer shown to be important for viral infection establishment 
(Diefenbach, 2015). A BAC20 DNA transfected cell that is then subjected to 
nocodazole treatment after 8 hours – before the onset of the late phase 
replication (McPherson and Delany, 2016) – could result in changes to the 
viral life cycle that would not normally occur. Additionally, the rounding up of 
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cells when treated with nocodazole described by Schumacher et al. (2005) 
could also mean the long-distance transport within cells that is facilitated by 
microtubules may no longer be required as the cell cortex is much closer to 
the nucleus.  
 
In this study, however, an already infected batch of cells at known plaque 
forming units (PFU) were introduced to the cell monolayer for 24 hours, 
allowing the establishment of infection before the introduction of 
depolymerising drugs. This incubation allows for a complete viral life cycle to 
occur and the infection to be established. Measuring viral plaque size after two 
and not five days also meant that the immediate effect of nocodazole on viral 
spread could be determined, rather than determining long-term effects of 
nocodazole treatment as infection may adapt to a lack of microtubules. It has 
been previously shown that when fibroblast cells (and RPE-1 cells) are 
constantly exposed to nocodazole they remain in mitosis for 10-48 hours and 
then arrest in G1 phase without a microtubule cytoskeleton but not undergo 
apoptosis (Uetake and Sluder, 2007). This suggests that after the initial shock 
of nocodazole treatment the cell will essentially carry on. This may also be true 
for an MDV infected cell that is treated with nocodazole for 5 days. 
 
Moreover, the incubation temperatures of cell culture were different in our 
studies. CEFs in this study were incubated at 38.5 ºC throughout cell 
maintenance. Schumacher et al. (2005) used 37 ºC. The natural body 
temperature of Gallus gallus is 41 ºC (Bolzani et al., 1979). Our cell culture 
conditions represent physiological conditions more than the conditions used 
by Schumacher et al. (2005). Temperatures different to physiological 
conditions could have drastic effects on intracellular Alphaherpesvirus viral 
spread (Cole, 1992).  
 
To conclude the difference in experimental design, and the fact that not all 
microtubules were depolymerized by Schumacher et al. (2005) could account 
for the discrepancy seen between the two studies. The findings that 
microtubules are essential for MDV viral spread opens a new avenue of study 
regarding the MDV life cycle. Understanding how microtubules are important 
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to the MDV life cycle could lead to new potential drug targets to treat MDV in 
the future.  
 
3.5.2: Cell Shape changes occur to MDV infected cells  
 
This study shows that cellular shape changes occur in MDV infected cells and 
depend on dynamic microtubules. Cell shape change during MDV infection 
has been studied previously in the context of viral plaques (Richerioux et al., 
2012). MDV viral plaques tend to spread in an organized manner following the 
regulated microenvironment created by the cellular monolayer. The 
microenvironment created by the cell monolayer is structured and favours 
actin stress fibre preservation and elongated cellular shape (Richerioux et al., 
2012). Similar viral plaque organisations were also seen in this study. 
However, in a sparse environment without the microenvironment-dictated 
boundaries of a confluent monolayer, MDV infected cells show drastic 
changes to the cell shape that are dependent upon dynamic microtubules.     
 
There are many differences between cells in 3D tissue and our 2D culture 
setup. Within tissues, cells are contained in a structured environment made 
up of the extracellular matrix (ECM). Neighbouring cells impose boundary 
conditions on each other that influence cell architecture, mechanics, cell 
polarity and function (Ingber, 2003, Ingber, 2006, Thery, 2010). In our 2D cell 
culture setup, cell shape is dictated much more by the adhesions cells make 
with the glass surface and ECM than outside influences from neighbouring 
cells (Duval et al., 2017) It may be much more relevant to study MDV viral 
spread in a 3D environment in the future to take in to account the restrictions 
imposed on to tissue architecture as a whole.  
 
The cell shape changes seen in this study could also be relevant to viral 
infection in vivo as macrophages are one of the main targets of MDV infection 
(Barrow et al., 2003). Macrophages go through stages of cellular shape 
changes when stimulated with cytokines to induce the M1 and M2 stages of 
activation (McWhorter et al., 2013). Macrophage shape is independent of 
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those cells around them as they can move freely between cells and depend 
upon short lived interactions with the ECM (Pixley, 2012). The cell shape 
changes induced during an MDV infection might play an important role during 
MDV viral spread in vivo as the many interactions macrophages have with 
cells in tissue could facilitate its rapid viral spread. Bringing together 3D cell 
culture and macrophage dependent MDV spread could be the next experiment 
to try to fully understand the cell shape changes induced, and how this relates 
to the larger picture of MDV pathogenesis. 
 
Other viruses like HIV-1 have been described to change cell shape and 
promote the formation of membrane extensions to facilitate cell-to-cell virus 
propagation (Nikolic et al., 2011). HSV-1 viral spread has also been shown to 
depend upon cell-to-cell contact, where viral capsids arrive at epithelial cell 
junctions from the TGN to infect neighbouring cells without having to leave the 
host (Akhtar and Shukla, 2009, Farnsworth and Johnson, 2006b). HSV-1 and 
HIV-1 are also able to produce viral particles that leave the host, unlike MDV 
that is entirely dependent upon cell-to-cell contact for viral spread (Nazerian 
et al., 1968, Solomon et al., 1968, Johnson et al., 1975). Therefore, MDV could 
have evolved to initiate changes to the cytoskeleton of the host to facilitate 
efficient and rapid viral spread.  
 
3.5.3: MDV infection does not require stabilized microtubules  
 
Other Alphaherpesviruses, such as HSV-1, have been shown to alter the host 
microtubule network, presumably to assist in viral spread (Brzozowska et al., 
2010, Dienes et al., 1987, Kotsakis et al., 2001, Kuhn et al., 2005, Mingo et 
al., 2012, Pasdeloup et al., 2013b). Viral proteins including US3 – a viral Akt 
mimic – stabilise microtubule arrays from the TGN towards the cell cortex and 
recruit +TIPs to capture microtubules at the cell periphery (Favoreel et al., 
2005, Naghavi et al., 2013). Other viral proteins like VP22 and have also been 
suggested to aid in the formation of acetylated microtubule arrays to stabilise 
existing microtubule structures further (Elliott and O'Hare, 1998). Cytoplasmic 
linker-associated proteins (CLASPs) are also recruited during 
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Alphaherpesvirus infection to encourage microtubule growth towards specific 
viral- glycoprotein-enriched regions of the plasma membrane (Hogue et al., 
2014b, Mingo et al., 2012). Stabilising and acetylating microtubules originating 
from the TGN and directing microtubule polymerisation towards specific 
sections of the plasma membrane could result in a stable and reliable method 
of transporting newly produced viral particles to the cell periphery.  
 
CEFs used during this study appear to have highly stable microtubules, with 
cold treatment assays resulting in none to very little change in the number of 
microtubules. Cold- stable microtubules have been described before, for 
example in mouse embryonic cells where suppressing the cold-stable 
properties of microtubules has been shown to disrupt synapse formation 
(Andrieux et al., 2002).  It can also be seen that the microtubules in CEFs are 
highly acetylated, which is thought indicate microtubule stability. This could be 
the reason why no changes to microtubule modifications were seen in MDV 
infected cells, as microtubules are already stable.  
 
3.6: Summary 
Based on the plaque assays performed, nocodazole treatment of MDV 
infection resulted in smaller plaque formation in a dose-dependent manner. 
Taxol treatment of MDV infection also results in significantly reduced viral 
spread in a dose-dependent manner. Using 500 pM Taxol does not obviously 
affect the microtubule network in individual CEFs but causes a significant 
reduction to viral spread suggesting viral infection requires dynamic 
microtubules. This suggests that microtubules are vital to the efficient spread 
of MDV to neighbouring cells. The effect of low dose Taxol on cellular shape 
showed that dynamic microtubules are instrumental to the cellular shape 
changes caused during infection. Treating MDV-infected CEFs with low dose 
Taxol results in dampening of the cell shape changes caused during infection. 
MDV infection does not result in changes to post-translational modifications 
on microtubules. CEFs have highly stable microtubules that are resistant to 
cold treatment.  
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Chapter 4: MDV capsids travel along microtubules 
 
One of the principal roles of microtubules is the facilitation of long-distance 
directional transport within the cell. Like other Alphaherpesviruses, MDV 
capsids that leave the nucleus must be trafficked to various sites (Wild et al., 
2017). Further transport from these sites to the cell cortex and cellular 
protrusions is also necessary for the spread of infection. Additionally, newly 
infecting virus also needs to be trafficked to the perinuclear region (Ward, 
2011). To investigate whether MDV viral capsids are transported via 
microtubules, a viral strain with a C-terminal GFP tag on the UL35 gene (RB1B 
UL35-GFP) (Kut and Rasschaert, 2004) was used. The UL35 gene encodes 
a small viral capsid protein that is incorporated into the outside of the viral 
capsid. This tag allows the visualisation of individual viral capsids within an 
infected cell.  
 
4.1: MDV viral capsids are transported on microtubules 
 
First, it was necessary to establish the requirement of microtubules for 
individual viral capsid transport. To do so, RB1B UL35-GFP infected CEFs 
were treated with 5 µM nocodazole (microtubule depolymerisation drug) for an 
hour prior to imaging. The bottom 1.5 µm of the cell was imaged as this is 
where most viral capsids and microtubules are located. The individual capsid 
dynamics in nocodazole treated cells were compared to those in DMSO-
treated cells. Movies generated were 3 minutes long. Viral capsid dynamics 
were determined by first tracking all viral capsids that were 5 µm away from 
the closest nucleus. The greatest distance each viral capsid travelled from its 
point of origin was then determined. If this was greater than 5 µm then that 
viral capsid was marked and shown as a ‘run’ suggesting active transport. Any 
viral capsid track lasting fewer than 100 frames was not considered for 
analysis unless the viral capsid had travelled more than 5 µm in that time 
frame. The reason for this cut-off was to ensure that viral capsids that moved 
out of focus during acquisition would not affect analysis.   
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CEFs infected with RB1B UL35-GFP have a very distinct appearance: the 
nucleus is packed with individual viral capsids, whereas the cytoplasm 
contains individual viral capsids that occasionally show directional movement 
or no movement, but mostly show diffusion-like behaviour (Fig 4.1A). When 
infected cells are treated with 5 µM nocodazole, directional movement is lost, 
and viral capsids mostly show diffusive behaviour (Fig 4.1A).  
 
Tracking each capsid individually revealed that on average ~10% of viral 
capsids travel over 5 µm in 3 minutes in DMSO treated cells. Active transport 
was largely lost when cells were treated with 5 µM nocodazole (Fig 4.1B). 
Nocodazole treatment resulted in a decrease in the average velocity of a viral 
capsids from 0.15 µm/s to 0.06 µm/s (Fig 4.1C). This suggests that 
microtubules are absolutely required for the active transport of MDV viral 
capsids. 
 
Next, the effect of stabilising microtubules and impairing microtubule dynamics 
and its effects on viral capsid transport was investigated. RB1B UL35-GFP 
infected CEFs were treated with 500 pM Taxol (MT stabilising drug) for 1 hour 
prior to imaging. Viral capsids were then imaged and analysed in the same 
way as the nocodazole data set. Viral capsids treated with Taxol showed very 
similar dynamics to the DMSO control (Fig 4.2A). Quantification revealed no 
differences between the percentage of viral capsids travelling more than 5 µm 
in 3 minutes in Taxol-treated versus DMSO-treated cells (Fig 4.2B).  This 
suggests that MDV viral capsids do not require dynamic microtubules for 
transport. The presence of microtubules alone is enough to facilitate active 
capsid transport.  
 
To confirm by visualisation that viral capsids are transported along 
microtubules, the cell permeable dye SiR-Tubulin was used on RB1B U35-
GFP infected cells (Lukinavicius et al., 2013). This dye allows visualisation of 
microtubules without the need for transfection (Fig 4.3A). Imaging both 
microtubules and viral capsids live revealed that viral capsids do move on 
microtubules (Fig 4.3). 
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The directional transport of viral capsids along microtubules is visible in areas 
of the cell with a relatively sparse microtubule network (Fig 4.3B). However, 
these areas are limited and are usually found near the cell cortex. In areas 
where the microtubule network is denser, individual microtubules can no 
longer be separated due to the resolution limitations associated with spinning 
disk microscopy. This caused problems with matching individual capsid 
transport with single microtubules in these dense microtubule areas of the cell 
(Fig 4.3B). A much higher resolution of at least 3-fold is required to 














Figure 4.1: Microtubules are required for viral capsid dynamics 
(A) Representative images of RB1B UL35-GFP infected CEFs, and nocodazole-treated RB1B 
UL35-GFP infected CEFs. GFP labels individual viral capsids. Scale bar is 20 µm. The green 
box indicates the area shown in the montage for DMSO treated cells. The red box indicates 
the area shown in the montage of 5 µM nocodazole-treated cells. Blue arrow indicates a viral 
capsid that travels over 5 µm. The orange arrow indicates a static viral capsid. Scale bar is 5 
µm.  (B) Quantification of the percentage of capsids that ran over 5 µm in 3mins. Data pooled 
from 3 independent experiments (n=30 cells for each condition total). Data shows mean ± 
standard deviation. Statistical significance *** p= <0.001 (two sample t-test). (C) Cumulative 
frequency plot shows the distribution of instantaneous velocities. DMSO and 5 µm Noc data 
show instant velocities from all cells at every time point. DMSO Runs data show instantaneous 
velocities of viral capsids that ran over 5 µm in 3min. Statistical significance *** p= <0.001 
(Kolmogorov–Smirnov test).       
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Figure 4.2: Dynamic microtubules are not required for viral capsid transport 
(A) Representative images of control RB1B UL35-GFP infected CEFs and Taxol-treated 
RB1B UL35-GFP infected CEFs. The green box indicates the area shown in the montage of 
DMSO-treated cells. The red box indicates the area shown in the montage of 500 pM taxol-
treated cells. Blue arrow indicates a viral capsid that travels over 5 µm. Scale bar is 20 µm.  
(B) Quantification of the percentage of capsids that ran over 5 µm in 3mins. Data pooled from 
3 independent experiments (n=30 cells for each condition). Data showing mean ± standard 








Figure 4.3: Viral capsids are transported along microtubules 
(A) Representative image of CEF infected with RB1B UL35-GFP and stained with SiR-Tubulin 
dye. Viral capsids shown in green and magenta shows microtubules. The yellow box highlights 
an area with low microtubule density, and white box indicates an area with high microtubule 
density. Scale bar is 20 µm. (B) Montage of the yellow box showing a viral capsid moving 
along a microtubule. White arrow indicates a viral capsid. Scale bar is 5 µm. (C) Montage of 
the white box showing viral capsid moving. White arrow indicates movement of a viral capsid. 







4.2: Viral capsids are transported along microtubules  
 
To fully characterise viral capsid behaviour on microtubules, a temporal 
resolution high enough to capture the fast movement of directional capsid 
movement and a super-resolution image of microtubules is required. MDV viral 
capsids are approximately 125 nm in diameter, and a fully mature virus with a 
tegument and envelope is ~200 nm in diameter (Ahmed and Schidlovsky, 
1968). Super-resolution images of viral capsids are not required as capsids 
are usually singular outside the nucleus (Fig 4.1A) and their large size means 
they can be resolved using approaches such as total internal reflection 
fluorescence (TIRF) microscopy and spinning disk confocal microscopy 
 
Super-resolution microscopy is required, however, to resolve individual 
microtubules. Microtubules have a diameter of approximately 25 nm 
(Mandelkow and Mandelkow, 1989), Techniques that can be employed to 
resolve them are Electron Microscopy (EM), Photoactivated localisation 
microscopy (PALM) (Zhang et al., 2017), live Stimulated Emission Depletion 
Microscopy (STED), Structured Illumination Microscopy (SIM) (Wegel et al., 
2016) and Stochastic Optical Reconstruction Microscopy (STORM) (Rust et 
al., 2006). STORM relies on the natural stochastic ‘blinking' of fluorophores 
usually used in fluorescence microscopy (Fig 4.4). However, this technique 
requires fixing samples, and therefore dynamic microtubule data cannot be 
obtained. Based on the limitations of each technique, combining 
confocal/TIRF microscopy with STORM was determined to be the best 
approach to try and address capsid dynamics on microtubules. This 
combination would provide the high temporal resolution required for 
characterising viral capsid dynamics and provide a super-resolution image of 
the microtubules to correlate with capsid dynamics. 
 
During standard STORM with our setup cells are directly seeded on to 
coverslips. Once ready cells are prepared for STORM and then a simple 
chamber is created directly on the coverslip containing the cells using motor 
grease and another coverslip. Then, STORM buffer is flown directly in to the 
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chamber containing stained cells and sealed. This chamber is directly 
mounted on to the microscope and STORM imagining is carried out on the 
coverslip containing the cells (Fig 4.4). This is a very straight forward and 
effective way of getting high resolution STORM images. 
 
Combining TIRF and STORM had to introduce changes to our standard 
protocol for STORM. The changes included the use of a gravity flow 
microfluidics chip system built on the in-house Warwick Open Source 
Microscope (WOSM) system capable of both TIRF and STORM (Fig 4.5) (see 
methods for greater detail). This was loosely based on a much more 
sophisticated microfluidics system developed previously (Tam et al., 2014). 
 
Three different generations of chambers were tested. Generation 1 was a 
simple design that had an output and input insert at each end for flow and a 
large viewing chamber for cell growth and imaging (Fig 4.5B). Using this 
chamber produced poor STORM reconstructions and the resolution obtained 
was no different to confocal microscopy (Fig 4.5C-D). Generation 2 chambers 
were slightly more complex and were designed to reduce the rate of flow into 
the viewing chamber by restricting flow into smaller channels before liquid 
reached the viewing chamber (Fig 5B). This produced much better staining of 
microtubules where they could be seen, but the resolution obtained for 
STORM was still poor (Fig 4.5C-D). Generation 3 chambers were designed to 
further slow down the flow of liquids into the viewing chamber to a rate of 50 
µl/s (Fig 4.5B). Also, bi-directional flow of fluids was used in this chamber: 
antibody-containing solutions were moved back and forth in the chamber 
during incubation. Of all the chamber designs tested, Generation 3 chambers 
provided the best STORM reconstructions, with a resolution of 160 nm (Fig 
4.5C-D). However, this resolution was still not close enough to the 30-50 nm 
resolutions achieved with our standardised STORM protocol (Fig 4.4). A 
second limitation with this approach was the lack of an environmental 
chamber, meaning the live imaging aspect of the experiment was carried out 
at room temperature, therefore not reflecting physiological conditions. 
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To address these issues correlative confocal spinning disk and STORM was 
carried out (Fig 4.6A-B) (see methods for further details). This addressed the 
environmental chamber issue and the low resolutions achieved with 
microfluidics. However, there were also some drawbacks to this approach, 
these being that the two images used for correlation could not be correlated 
accurately in the Z dimension. X and Y dimension correlations were achieved 
simply by using viral capsids as markers for a reliable correlation. However, it 
is not possible to determine whether the live capsid movies and the STORM 
images were taken in the same Z. This caused some capsids to appear to run 
in areas where no microtubules were present. Another limitation was that the 
super-resolution microtubule image was static from the end point of the movie 
and no information regarding the position of the microtubule during the movie 
could be obtained. Growth and shrinkage of microtubules could affect the viral 
capsid dynamics, and there was not a way of determining whether either had 
occurred with this approach. Therefore, super-resolution imaging of live 
microtubules along with live capsid dynamics is required.      
 
To achieve live super-resolution imaging, the newly developed Super-
Resolution Radial Fluctuations (SRRF) microscopy technique was employed 
(Gustafsson et al., 2016). This approach allows the use of conventional 
microscopes including widefield, confocal and TIRF to generate super-
resolution images from live (or fixed) cells. The achievable resolution is stated 
at 60 nm (Gustafsson et al., 2016) , although only 100 nm resolutions were 
obtained during this study. This was still a significant increase in resolution 
compared to the correlative super-resolution and confocal microscopy 
attempted previously and was sufficient to study viral capsid dynamics in live 
cells. Individual viral capsids were matched to microtubules reliably using this 
method (Fig 4.7A-C) This was achieved by separating the two channels 
imaged, generating SRRF images for the microtubules and then recombining 
the super resolution microtubule image to the capsid images (see methods for 
more detail).   
 
Using SRRF microscopy to correlate individual viral capsid runs to single 
microtubules provided insights into the characteristics of viral capsid 
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behaviour. All SRRF movies were a minute long. Viral capsids outside the 
nucleus showed that 89.4 % are associated with microtubules.  Within this, 
56.6% (±13.6 %) are stuck or pausing and showing little or no directional 
transport. Directional transport was observed with 11.8 % (± 4.8 %) of viral 
capsids outside the nucleus. Bi-directional transport was observed with 3.7 % 
(±1.6 %) capsids suggesting multiple motors transporting viral capsids. 
Microtubule track switching was observed with 9.1 % (±6.6 %) of viral capsids 
outside the nucleus. Diffusion of capsids along microtubules was observed 
with 5.1 % (±1.8 %) of viral capsids. Occasional binding of capsids to 
microtubules but not being transported was observed with 3.1% (±2.8 %) of 
capsids (Table 9). Together, these findings suggest that the majority of viral 
capsids outside the nucleus are engaging with microtubules even though only 







Figure 4.4: Workflow of STORM 
Schematic workflow of STORM. The cell of interest was imaged using conventional 
microscopy first as a reference image. Using 100 kW/cm2 647 nm laser power all the 
fluorophores were forced into a dark state. Once sufficiently bleached, 647 nm laser power 
was reduced to 40-60 kW/cm2 to promote stochastic blinking of the fluorophores. 1-5 kW/cm2 
of 405 nm laser was also used to promote blinking events. The acquisition is started at this 
point. After a sufficient number of frames (~20,000) are taken, the acquisition is stopped. Then 
the localised point of each ‘blink' from each frame is calculated using a normalised Gaussian 
curve. Each point is then superimposed on to a single image to form a reconstructed STORM 
image. By fitting each molecule to an exact position, the diffraction limit is eliminated, and 






Figure 4.5: Microfluidic STORM 
(A) Representative image of TIRF microscopy showing microtubules and a line intensity scan 
of a single microtubule demonstrating the width of a microtubule which is the resolution 
achieved with TIRF microscopy. (B) Schematics of the chambers designed and used. Arrows 
indicate the direction of flow in each generation. Viewing chamber is where the cells were 
seeded, grown and imaged. (C) STORM reconstructions of microtubules from each chamber. 
Images show the best STORM images obtained from each chamber generation. (D) Line 
intensity scans showing the width of a single microtubule to demonstrate the resolution 






Figure 4.6: Correlative spinning disk confocal microscopy and STORM 
(A)  Schematic representation of the workflow for correlative confocal and STORM 
microscopy. First, the infected cells are imaged live, fixed on stage and then prepared for 
STORM. A STORM image of the microtubules is then generated. The movie of viral capsids 
and the STORM image is then correlated in X and Y using the viral capsids as landmarks. 
The red box indicates the area that was used for STORM. (B) Montage of viral capsid showing 
directional transport on microtubules. Blue arrow indicates and follows a single viral capsid. 














Figure 4.7: Live SRRF microscopy and viral capsid dynamics 
(A) Representative images comparing spinning disk confocal microscopy (left) and SRRF 
microscopy (right) images of the same cell. The image shows viral capsids in green and 
microtubules in red. The yellow box indicates the area shown in the montages. Scale bar is 
20 µm. (B-C) Montage of viral capsid moving along microtubule from confocal 
microscopy/SRRF microscopy. Orange arrow indicates static viral capsid and blue arrow 


















Viral capsid that is not 
associated with a 
microtubule and is not 
showing any signs of 
diffusion 







Viral capsid that is diffusing 
and is more than 500 nm 
away from the nearest 
microtubule 







Viral capsid that is diffusing 
and is less than 500 nm 
away from the nearest 
microtubule and not binding 
to it 







Viral capsid that is clearly 
on a microtubule and is not 







Viral capsid that is 
directionally travelling on a 
microtubule and travels over 
500 nm in distance 







Viral capsid that is showing 
directional movement in 
both directions on the same 
microtubule 






Viral capsid that is switching 
microtubules – usually 
multiple times during the 
acquisition 









Viral capsid that is diffusing 
and is less than 500 nm 
away from the nearest 
microtubule and binding to it 







Viral capsid that is travelling 
on a microtubule in a non-
directional manner and 
travels under 500 nm in 
distance 




Table 9: Summary of viral capsid dynamics  
Quantification from SRRF movies. Total of 385 capsids were analysed from 19 cells from 3 
independent experiments. Note: a single viral capsid can be attributed to multiple events, i.e. 
a running capsid that is directionally transported over 500 nm then stops and then switches 




















4.3: Viral capsids are in very close proximity to microtubules in the 
cytoplasm  
 
Using super-resolution microscopy to identify viral capsid interactions with 
microtubules has shed light on capsid dynamics. However, the nature of these 
viral capsids is not known and whether these capsids possess an envelope is 
a question that remains to be addressed. Determining whether viral capsids 
poses an envelope in the cytoplasm can help understand how viral capsids 
are transported. To attempt to understand at which stage of maturation these 
capsids are, e.g., if they have a viral membrane or are they in vesicles, EM 
was employed. RB1B UL35-GFP infected CEFs were pelleted, high-pressure 
frozen, stained with heavy metals, embedded in resin, sectioned and then 
imaged. Infected cells were first identified by searching for a nucleus that 
contained viral capsids. Various cytoplasmic regions that contained viral 
capsids were then imaged (Fig 4.8).  
 
Infected cells are easily identifiable as viral capsids are electron dense and 
have a distinct structure. In infected cells, the nucleus contained many viral 
capsids, and some capsids could also be seen in the cytoplasm (Fig 4.8A). 
Investigating cytoplasmic capsids further revealed three distinct states for viral 
capsids; the naked capsid that lacks an envelope and is approximately 125 
nm in diameter (Fig 4.8B); the fully enveloped viral capsid with an approximate 
diameter of 200 nm (Fig 4.8C); or the naked viral capsid/ fully enveloped virus 
within a vesicle of varying sizes (Fig 4.8D). Most viral capsids observed 
outside the nucleus were naked viral capsids (31/36). Enveloped viral capsids 
comprised only a small fraction of total capsids observed (5/36). A small 
percentage of viral capsids were in vesicles (4/36) and of that population, 75 
% (3/4) were naked capsids and 25 % (1/4) were enveloped.  
 
The distance between each viral capsid and the closest microtubule was also 
measured. As a negative control each viral capsid was shifted by 200nm and 
the distance to the nearest microtubule was measured again. This method 
ensured that if microtubules were randomly near viral capsids then there would 
 97 
be no difference between the shifted viral capsid and actual viral capsids 
distance a microtubule. The median distance of viral capsid to a microtubule 
is 143 nm whereas when shifted this increased to 179 nm in the negative 
control suggesting viral capsids are close to microtubules. However, 
statistically this is insignificant, possibly due to low n numbers present in our 
study.  
 
There are other studies that have shown that Alphaherpesvirus capsids from 
HSV-1 infection are also in close proximity to microtubules using electron 
microscopy techniques. Immunoelectron microscopy was used to show that 
cytosolic capsid transport of HSV-1 particles in Vero cells is mediated by 
microtubules and that viral capsids are indeed in very close proximity to 
microtubules (Sodeik et al., 1997). Additionally, immunoelectron microscopy 
targeting Kinesin-1 has shown that HSV-1 particles are being transported 
along microtubules in neurons (Miranda-Saksena et al., 2009). Therefore, our 
findings are in line with the consensus that Alphaherpesvirus particles are in 

















Figure 4.8: Viral capsids are very close to microtubules and lack viral envelopes  
(A) CEF cell infected with RB1B UL35-GFP. The cell was stained with heavy metals and 
sectioned into 200 nm thick sections. This is a 2500 x magnification. Scale bar is 1 µm. The 
black boxes indicate from where the images in B, C and D are derived. (B) A naked viral 
capsid in the cytoplasm. 40k x magnification. Scale bar is 100 nm. (C) A viral capsid with an 
envelope. 40k x magnification. Scale bar is 100 nm. (D) A enveloped viral capsid inside a 
vesicle. 60k x magnification. Scale bar is 100 nm.  For all inserted images, a raw image and 
an annotated image is shown. Green is a viral capsid. Orange is a viral envelope. Blue is a 
vesicle. Purple is a microtubule. (E) Cumulative frequency plot showing distribution of the 
distances measured of viral capsids to the closest microtubule. In red is the actual distance to 
the closest microtubule for each viral capsid. In black is the 200 nm shifted viral capsid 
distance to the closest microtubule.  N = 32 viral capsids and 3 cells. Statistical significance 









4.4.1: Super-resolution microscopy  
 
Recent advances in super-resolution microscopy have enabled the 
visualisation of subcellular structures that are too dense to be separated with 
classical optical techniques. However, super-resolution approaches such as 
STORM can only be applied to fixed samples or live samples that require very 
low (minutes) temporal resolutions. To overcome this, we attempted 
correlative live cell imaging of viral capsids and STORM imaging of 
microtubules. Combining live imaging and STORM had been achieved before 
with the use of a computer-controlled fluid injection system and multi-
channelled flow switching system (Tam et al., 2014). The system used in this 
study was a single channel gravity flow-controlled microfluidics chip, which 
was a much simpler approach.  
 
Established protocols were used in the microfluidics chips for seeding cells, 
immunostaining and STORM imaging.  This resulted in poor STORM images. 
One of the first problems that needed addressing with this approach was the 
low number of cells adhering in the viewing chamber of the chip. This effect is 
common and usually seen in blood cells flowing through capillaries: the 
Fahraeus-Lindqvist effect (Lindqvist, 1931). This effect describes how fluids 
become less viscous as the diameter of tubing gets smaller. This results in 
lower density of cells flowing though the tubing and therefore fewer cells being 
seeded. This problem was overcome by increasing the number of cells seeded 
by 20-fold. The second problem with this approach was the poor quality of the 
STORM images obtained. This was be attributed to the fact that most sample 
preparation protocols are optimised for materials like polystyrene and glass. 
These have very different material properties compared to PDMS (Berthier et 
al., 2012). PDMS tends to absorb small molecules (Toepke and Beebe, 2006) 
and can change the local concentrations of some reagents unpredictably. 
These characteristics of PDMS could have resulted in the poor STORM 
reconstructions obtained from the microfluidic chips used in this study. 
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Previous studies have overcome this problem by going through a stepwise 
optimization procedure for each chip (Tam et al., 2014). Carrying out a similar 
procedure was not possible within the limited time-frame of this study. 
 
In order to overcome the poor STORM reconstructions, the method was 
changed to correlative spinning disk and STORM microscopy. This approach 
used an established STORM protocol that would provide the resolution 
required to resolve microtubules. Correlative spinning disk and STORM 
proved to provide the temporal and optical resolution required for addressing 
viral capsid dynamics on microtubules. However, significant limitations with 
this approach were also encountered. The main issue was the lack of reliable 
Z correlation between the spinning disk image and the STORM image, as 
these were obtained from two different microscopes. Correlating in the Z 
dimension was near impossible without obtaining 3D movies of viral capsids 
and STORM images. 3D movies were not possible as viral capsid transport is 
a very rapid process and at least 2-3 Hz is required for reliable tracking. Lattice 
Light Sheet Microscopy (LLSM) could be used to achieve the 3D temporal 
resolution but finding the same cell again on the WOSM would be near 
impossible. Also obtaining 3D STORM images was not possible at the time 
while using the WOSM system. This resulted in abandoning this approach. 
 
Recently, other studies were able to correlate live and super-resolution images 
(Xiang et al., 2018). This was achieved by using 3D live imaging and STORM 
images to achieve correlation not only in X and Y also in the Z dimension. No 
fiducial markers were required during their study as the object of study; 
replication domains produce distinct structures that was be used instead.  
 
SRRF microscopy was the super-resolution microscopy technique that was 
able to finally meet the criteria required to associate MDV viral capsid 
dynamics to microtubules. This was a much simpler approach compared to all 
the correlative work that was attempted previously and proved to be an 
indispensable tool to finally study viral capsid dynamics. SRRF has been used 
to study a wide range of cellular functions (Khan et al., 2017, Retzer et al., 
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2017, Weihs et al., 2018) but this is the first time it has been used to study viral 
infection to the best of our knowledge.  
 
4.4.2: Viral capsids are associated with microtubules  
 
Microtubules and their associated motor proteins are involved in 
Alphaherpesvirus capsid transport (Dohner et al., 2002, Mabit et al., 2002, 
Pasdeloup et al., 2013a, Pasdeloup et al., 2013b, Sodeik et al., 1997). 
However, MDV capsid transport has not previously been associated with 
microtubules. The only reference to MDV infection associating with 
microtubules was the suggestion that MDV VP22 from MDV is associated with 
microtubules (O'Donnell et al., 2002), and only shown via 
immunofluorescence. To the best of our knowledge this study is the first to 
show that MDV viral capsids are not only associated with microtubules but are 
actively and directionally transported along them.  
 
Viral capsid behaviour was characterised in this study, with many viral capsids 
observed showing very little directional transport during image acquisition. 
This was surprising as viral capsids on microtubules would be expected to be 
transported along rather than statically bound to microtubules. Other studies 
have also reported stalled/stationary capsids bound on microtubules. PRV 
viral capsids that are transported along microtubules via Kif1A during egress 
included up to 30% of viral capsids that were stationary but remained bound 
to the microtubules (Kramer et al., 2012). Therefore, having a high number of 
stationary capsids may be expected. This phenomenon could be a result of 
limited imaging time, as only a snapshot of time is taken from an infected cell 
and catching all viral capsids undergoing directional transport during this time 
is not possible. The fact that these viral capsids are bound to microtubules and 
remain bound to microtubules during image acquisition also indicates the 
possibility that these viral capsids will undergo directional transport eventually.   
 
Bi-directional transport of MDV viral capsids was also observed in this study. 
HSV-1 and PRV viral particles have both also been described to be 
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transported in a bi-directional manner (Antinone and Smith, 2010, Smith et al., 
2001, Smith et al., 2004). This bi-directional transport is probably a result of 
viruses avoiding obstacles on microtubules, such as other cargo and may 
occur to ensure that they are trafficked to the right cellular location. This model 
was suggested for general cellular cargos and can be applied to viruses as 
they are essentially considered cargo by the host (Welte, 2004). The fact that 
viruses employ bi-directional transport raises several questions regarding a 
net direction of viral transport towards the cell periphery and how is this 
controlled during viral entry and egress. Few models are proposed for bi-
directional transport. The first is that a tug-of-war exists between plus end and 
minus end-directed motor proteins that transport viral capsids. It is thought that 
the number of motors and their competing activities define the direction of 
travel (Akhmanova and Hammer, 2010, Hendricks et al., 2010, Muller et al., 
2008, Shubeita et al., 2008, Soppina et al., 2009, Verhey et al., 2011). The 
second model is that the opposite polarity motors regulate the activity of each 
other as they are usually coupled together (Akhmanova and Hammer, 2010, 
Ally et al., 2009, Encalada et al., 2011, Gennerich and Vale, 2009). Other 
models are the microtubule tethering state and the steric disinhibition models 
(Hancock, 2014). It would be essential to address how bi-directional MDV 
capsid transport is regulated in the future. This can be achieved by either 
purifying entire MDV viral particles with motors and adaptors still bound to 
them or tagging potential motors and adaptors with fluorescent markers and 
visualizing interactions in cells, or by rebuilding the entire transport system 
with viral capsids in vitro.   
 
4.4.3: Most MDV viral capsids in the cytoplasm lack an envelope 
 
This study has shown that most MDV viral capsids in the cytoplasm lack an 
envelope. This suggests that there is a large population of viral particles 
present in the cytoplasm awaiting secondary envelopment. In other 
Alphaherpesviruses such as HSV-1 and PRV there has been some 
controversy as to whether viral capsids observed with directional movement 
possess a viral envelope or a tegument layer. Using fixed cell imaging, it was 
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not possible to determine whether the viral capsid possesses a viral envelope 
and has undergone transport (Saksena et al., 2006, Snyder et al., 2006). 
However, with live cell imaging, 70% of viral capsids undergoing directional 
transport were determined to have a viral envelope (Antinone and Smith, 
2006, Antinone et al., 2010, Feierbach et al., 2007). It was also determined 
that the majority of HSV-1 and PRV particles were found within vesicles 
(Avitabile et al., 1995, Huang et al., 2011, Maresch et al., 2010, Negatsch et 
al., 2010). However, only a small fraction of MDV viral capsids were in 
vesicles. 
 
There are some significant differences from the studies already carried out 
with HSV-1 and PRV, and this study. Firstly, the cell types employed: the 
majority of HSV-1 and PRV work is carried out in cultured neurons and Vero 
cells, whereas all the work in this study was carried out in primary chicken cells 
(mainly embryonic fibroblasts) due to the fact the wild-type MDV only infects 
primary cells in culture. Different cell types may result in different secretory 
pathways to be exploited resulting in changes to the viral life cycle (Huang et 
al., 2005). Therefore, the viral membrane could be obtained much later 
resulting in a higher percentage of viral capsids waiting for secondary 
envelopment. Additionally, although MDV is in the same family as HSV-1 and 
PRV, there could be critical differences in viral capsid maturation and 
secondary envelopment, and it would be interesting to investigate these in the 
future. Determining that most MDV viral capsids lack an envelope needs to be 
verified with the use of viral envelope markers, which would also allow 









4.5 Summary  
 
MDV Viral capsids are shown to be transported on microtubules: removal of 
microtubules prevent the directional transport of MDV capsids. However, 
artificially stabilising microtubules with Taxol did not affect viral capsid 
transport, suggesting that microtubule dynamicity is not required for active 
transport. Super-resolution microscopy reveals that the majority of viral 
capsids outside the nucleus associate with microtubules and are transported 
on them. Electron microscopy suggested that most viral capsids in the 
























Chapter 5: Kinesin-3 transports viral capsids 
 
Based on the findings that MDV viral capsids are transported directionally 
along microtubules, the molecular motors responsible for transporting viral 
capsids were investigated. Alphaherpesvirus capsids undergo directional 
trafficking, and the molecular motors dynein and kinesins are responsible for 
this (Antinone and Smith, 2006, Antinone et al., 2010, Hirokawa et al., 2009, 
Radtke et al., 2010). Dynein is a minus end directed molecular motor 
responsible for transporting a wide range of cargo towards the centre of the 
cell (Flores-Rodriguez et al., 2011, Roberts et al., 2013, Rogers et al., 2001, 
Rogers et al., 2010). Kinesin-3s are fast organelle, endosome and 
mitochondria transporters (Siddiqui and Straube, 2017, Yamada et al., 2014, 
Yue et al., 2013).  
 
5.1: Kif13B transports MDV viral capsids. 
 
To identify promising candidates for viral capsid transport from the 45 possible 
kinesins, a split kinesin assay was employed. This assay, developed by the 
Banker Lab (Jenkins et al., 2012), is dependent upon a chemical dimerisation 
inducer – rapamycin (Choi et al., 1996). During this assay, CEFs are 
transfected with two plasmids. The first plasmid expresses a Kif5C motor 
domain with a tdTomato marker and an FRB domain on the C-terminus. Kif5C 
motor domains can bind and travel on microtubules, however, this protein is 
not able to bind to cargo as it lacks all cargo binding domains found on the tail 
region of kinesins. The lack of a tail means that the protein is constantly active: 
once on a microtubule it will continue to travel towards the plus end with 
minimal regulation, which is usually provided by the tail region. The second 
plasmid expresses the tail domain of a kinesin of choice (see methods – split 
kinesin assay) that lacks a motor domain but has an FKBP domain on the N-
terminus. This tail can bind to its native cargo but lacks the motor domains to 
bind to microtubules and transport them. These two truncated proteins remain 
independent until the addition of rapamycin to bring the FRB and FKBP 
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domains together to form a chimeric kinesin, that is capable of binding both to 
MTs and to cargo.  
 
The approach taken was to individually express a different kinesin tail with the 
Kif5C motor domain in CEFs. These cells were seeded in co-culture with 
infected cells. After 2 days, 0.5-1% of the transfected cells became infected. 
The kinesin tail expressed in an infected cell might bind to the viral capsid, 
enveloped virus or a vesicle containing the viral particle but be unable to 
transport it. Upon addition of rapamycin a chimeric kinesin bound to the viral 
capsid might be formed and transport the viral capsid along microtubules. In 
this case, a detectable change in viral capsid dynamics was observed after 
introducing rapamycin. If the expressed kinesin tail does not associate with 
the viral capsid, no change in dynamics was observed following rapamycin 
addition (Fig 5.1A-B).   
 
As expected, the dynamics of viral capsids in non-transfected and motor 
domain only transfected cells did not significantly change upon addition of 
rapamycin (Fig 5.1C). Co-expressing the Kif5C (kinesin-1 family) tail domain 
with the Kif5C motor domain resulted in a dramatic reduction in the percentage 
of viral capsid runs over 1.5 µm/min. Expression of Kif17 (kinesin-2 family) 
resulted in no observable change to dynamics. Kif1A, Kif1Ba, Kif1Bb, Kif13A 
and Kif13B (kinesin- 3 family) tail domain all showed an increase in the 
percentage of viral capsid runs over 1.5 µm/min. This suggests that that tail 
domain from these kinesins may be interacting with viral capsids. Kif13B was 
the only kinesin-3 family member to show a statistically significant increase in 
viral capsid dynamics. Kif21B (kinesin-4 family) also showed a slight increase 
in the number of capsids that travelled over 1.5 µm/min, although not 
statistically significant (Fig 5.1C). These findings suggest that Kif13B could be 
responsible for transporting viral capsids during egress.  
 
To further confirm these findings, a short hairpin RNA (shRNA) mediated 
knockdown approach was employed. Plasmids that express two different 
shRNAs to target Kif13A and Kif13B were employed as well as shRNA against 
luciferase as a control. These plasmids also expressed mCherry tagged α-
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tubulin to aid the identification of transfected cells. Transfected CEFs were 
maintained together with CEFs infected with RB1B UL35-GFP virus. 
Transfected cells that became infected were then imaged, and viral capsids 
dynamics were measured (Fig 5.2A). 
 
Approximately 17% of viral capsids travelled more than 3 µm when transfected 
with shRNA against luciferase. This decreased to ~12 % when treated with 
shRNA (1) and ~14 % with shRNA (2) against Kif13B (Fig 5.2C). These 
changes were statistically significant. No significant change to capsid 
dynamics was observed with shRNAs against Kif13A (Fig 5.2C). shRNA 
Kif13B (1) was effective at reducing mRNA levels, whereas both shRNAs 
against Kif13A were not (Fig 5.2B). In line with this, only shRNA against Kif13B 
caused a significant reduction in viral capsid transport. These findings suggest 
that reducing the levels of Kif13B mRNA results in fewer viral capsids that are 
actively transported and therefore that Kif13B contributes transporting MDV 
viral capsids during egress. The drop from 17% to 12% must be considered 
biologically significant as high levels of redundancy between kinesin family 
members make it hard to completely knock-down 100% of transport as other 
kinesins are thought to take over transport. From the split-kinesin-assay all 
kinesin-3 family members showed a slight increase in capsid transport 
suggesting multiple members could transport viral capsids, therefore by only 
knocking out a single member of the kinesin-3 family a massive drop in capsid 














Figure 5.1: Split Kinesin Assay: Kinesin 3’s transport MDV capsids  
(A) Schematic describing the split kinesin assay. Briefly; In wild type a kinesin would 
interact with the viral particle to transport it along a microtubule. During the split kinesin 
assay CEFs are transfected with the Kif5C motor domain fused to FRB and a kinesin tail 
domain fused to FKBP. The tail domain either interacts with the viral capsid or does not. 
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Upon addition of rapamycin, the Kif5C motor domain, and the tail domain come together 
to form a chimeric kinesin. If the tail is bound to a viral capsid, then this results in directional 
transport of the viral capsid.  (B) Representative images of CEFs infected with RB1B UL35 
GFP (green) also expressing Kif5C motor domain with a tdTomato marker (red). Scale 
bar is 20 µm. Green box indicates area in montage showing viral capsids being 
transported during a split kinesin assay. Blue arrows are indicating and following a viral 
capsid. Scale bar is 5 µm (C) Graph showing quantification of the percentage (%) of viral 
capsids that travelled more than 1.5µm/min. Black bars represent quantification of viral 
capsids dynamics before rapamycin, and red bars represent after rapamycin addition. Red 
bars were normalised for the effects of photobleaching, black bars did not require 
normalization. The kinesin tail transfected is stated below each pair of bars. N numbers 
are indicated blow each condition. Statistical significance is p <0.05 = * (Paired t-test). 















Figure 5.2: Knock-down of Kif13B reduces the number of running capsids  
(A) Representative image of CEF transfected with plasmids expressing shRNA Luc and 
shRNA Kif13B(1) also expressing mCherry tubulin (red) as a marker for successful 
transfection and infected with RB1B UL35 GFP (green). Scale bar is 20 µm. Green box 
indicates montage of viral capsid transport from shRNA Luc treated cells. Red box indicates 
montage of viral capsid transport from shRNA Kif13B(1) treated cells. Blue arrow indicates 
and follows viral capsid being transported. Orange arrow indicates stationary capsid. Scale 
bar is 5 µm. (B) PCR using cDNA made from whole cell mRNA. Primers were against Kif13A, 
Kif13B and GAPDH. (C) Graph showing quantification of the percentage (%) of viral capsids 
that travelled over 3 µm during acquisition. The black bar is negative control shRNA against 
luciferase, and red bars are shRNA against Kif13A and Kif13B (two separate shRNAs used 
for each kinesin). n.s. is not significant, p <0.05 = * p<0.005 = ** p<0.0005 = *** (two-sample 





5.2: Dynein also transports MDV capsids 
 
MDV viral capsids display bi-directional behaviour during egress (Table 9), 
and this suggests that minus end-directed motors may also be involved in 
transporting viral capsids. Cytoplasmic dynein is the major minus end-directed 
cargo transporter. To determine whether dynein is involved in transporting viral 
capsids Ciliobrevin D was used to inhibit the ATPase activity of dynein 
preventing it from stepping and therefore halting cargo transport (Cao et al., 
2003, Chou et al., 2011, Firestone et al., 2012, Janiesch et al., 2007, Sainath 
and Gallo, 2015, Ye et al., 2001). CEFs infected with RB1B UL35 GFP virus 
were treated with 100 µM Ciliobrevin D for an hour prior to imaging. The 
distance viral capsids travel was then quantified.    
 
There is a drastic reduction in viral capsid transport upon treatment with 
Ciliobrevin D: only 5.4 % of viral capsids travel over 3 µm in 3 minutes 
compared to the DMSO control of around 29.3 % (Fig 5.3A-B). This suggests 
that the ATPase activity of dynein is crucial to viral capsid dynamics. The loss 
of dynein's cargo transporting abilities suggests that dynein is also required 

















Figure 5.3: Ciliobrevin D treatment reduces the distance viral capsids travel.  
(A) Representative images of control RB1B UL35 GFP infected CEFs, and 100 µM CilD 
treated RB1B UL35 GFP infected CEFs. GFP highlights individual viral capsids. The green 
box indicates the area shown in the montage of DMSO treated cells. The red box indicates 
the area shown in the montage of 100 µM Ciliobrevin D treated cells. Blue arrow indicates a 
viral capsid that travels over 3 µm. Orange arrow indicates stationary capsid. Scale bar is 20 
µm.  (B) Quantification of the percentage of capsids that ran over 3 µm. n=20 cells for each 
condition. Error bars are the standard deviation. Statistical significance *** p= 0.0005 (two 






This study has shown that Kif13B contributes to the transport of MDV viral 
capsids towards the cell periphery. Dynein is also required for transport (Fig 
6.1). Knockdown of Kif13B results in about a 30% reduction of directional 
transport events. This significant but not dramatic reduction points towards the 
possibility that there may be redundancy amongst the motors that transport 
MDV capsids and Kif13B may not be the only plus end-directed motor 
contribute MDV capsid transport. The split kinesin assay hinted at the 
possibility of various kinesin-3 family members being able to transport MDV 
capsids as all the tail domains of kinesin-3 family members showed a slight 
increase in the number of capsids being transported but Kif13B was the only 
statistically significant tail domain to suggest transport. Lack of statistical 
significance does not necessarily rule out the biological significance of other 
kinesin-3 members transporting MDV, especially as the number of repeats 
were low due to the difficulty of the experiment. There is significant redundancy 
in cargo transport between kinesins (Goldstein, 1991). Therefore, it could be 
speculated that several kinesins-3s (Kif1A, Kif1Ba, Kif1Bb, Kif13A and Kif13B) 
would contribute to MDV viral capsid transport but Kif13B could be the 
dominant transporter. 
 
Another motor that may be involved in transporting MDV viral capsids is the 
minus end directed cytoplasmic dynein. By inhibiting the ATPase activity of 
dynein, it was possible to reduce the percentage of viral capsid transport by 
73%. This suggests that dynein is a major transporter of MDV viral capsids. It 
is interesting that such a dramatic reduction in capsid transport occurs when 
dynein is inhibited. This could be due to the fact that kinesin-3 motor proteins 
usually do not transport cargo without an adaptor protein and the dynein 
complex being present (Ally et al., 2009, Bielska et al., 2014, Theisen et al., 
2012, Tien et al., 2011). It can be hypothesised that inactive dynein also fails 
to initiate viral capsid transport mediated by kinesin-3 motor proteins, resulting 
in a significant reduction in viral capsid transport.  
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Several motor proteins were identified to transport other Alphaherpesviruses 
capsids. Dynein is required for Alphaherpesvirus viral particle transport 
(Dohner et al., 2002, Mabit et al., 2002, Zaichick et al., 2013). It has been 
suggested that tegument proteins UL36 from PRV couple the dynein/dynactin 
complex to the viral capsid by associating with dynactin and viral capsid 
protein UL25 (Dohner et al., 2002). This distinct method of recruiting dynein to 
PRV viral capsids raise questions regarding how MDV viral capsid could 
recruit dynein to the newly formed viral capsid or newly invading viral particles. 
 
The Kinesin-3 family member Kif1A has been shown to directly interact with 
the viral protein US9 to promote plus end-directed transport during egress of 
PRV viral particles. The same protein (US9) from HSV-1 has been shown to 
recruit kinesin-1 to facilitate egress (Diefenbach et al., 2016, DuRaine et al., 
2018) additionally,  US11, a tegument protein has been shown to bind to 
kinesin-1 (Diefenbach et al., 2002). Based on these findings it is possible to 
hypothesise that MDV viral capsids could recruit Kif13B via the tegument 
protein US11 to promote transport of nucleocapsids or via US9 to promote 
transport of enveloped viral particles. This could be confirmed in the future by 
using a knockout MDV virus or by fluorescently tagging each component of 





By using a split kinesin assay, kinesin-3s have been shown to be involved in 
the transport of MDV viral capsids during egress. Knocking-down Kif13B using 
shRNA has shown that fewer viral capsids are directionally transported. This 
suggests Kif13B contributes to the transport of viral capsids during egress. 
The requirement of dynein during egress was also confirmed by using a dynein 
inhibitor. The number of viral capsids that showed directional transport 
reduced significantly when treated with Ciliobrevin D. This suggests that 
dynein is crucial to viral capsid transport during egress.  
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Chapter 6: General discussion  
 
Egress, the transport of viral particles from site of origin to cell periphery is a 
necessary process for efficient intra and intercellular viral spread. Here, the 
requirement of the host cytoskeletal elements, microtubules and actin during 
MDV infection was described. It was shown that cells undergo cell shape 
changes during MDV infection, which requires dynamic microtubules. 
Individual viral capsids are associated with microtubules and most viral 
particles in the cytoplasm lack an envelope. Furthermore, it has been shown 
that Kif13B and dynein are responsible for viral capsid dynamics during 
egress. All these findings together suggest that microtubules are essential for 
efficient MDV viral spread. 
 
Findings from this study are important for two separate fields of study; 
herpesvirology and microtubule motors. Firstly, it provides evidence for 
microtubule-based transport of MDV, which was previously thought not be 
directly involved in the MDV life cycle. This finding is in line with other 
Alphaherpesviruses like HSV-1 suggesting that microtubules are essential for 
their life cycles (Akhtar and Shukla, 2009, Diefenbach et al., 2002, Kotsakis et 
al., 2001, Mettenleiter, 2002). By first showing that microtubules are important 
for efficient viral spread by using plaque assays it has been established that 
microtubules play an important role during the MDV life cycle. This is an 
important establishment as it opens a brand-new avenue of study for the MDV 
virology field. Research that was previously carried out suggesting that 
microtubules are dispensable for MDV infection (Schumacher et al., 2005) 
would need to be re-evaluated and the importance of microtubules would need 
to be considered for future experiments. By using super-resolution microscopy 
it has been shown that MDV viral particles are directly transported on 
microtubules, and this finding is in line with other studies carried out with HSV-
1 and PRV, where live cell imaging, in vitro reconstitution and, correlative live 
and electron microscopy showed HSV-1 and PRV viral particles being 
transported on microtubules (Ibiricu et al., 2011, E Lee et al., 2006, Hogue et 
al., 2014a).  
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To the best of our knowledge it is the first time for a study to use SRRF 
microscopy to study herpes virus transport in infected cells. This is an 
important milestone to show that these new techniques can be employed to 
understand and illuminate previously unknown aspects of MDV viral infections. 
Using super-resolution microscopy can further aid in understanding certain 
aspects of the Alphaherpesvirus life cycle, for example, dSTORM has been 
used to illuminate and identify where certain tegument proteins are located in 
a mature HSV-1 viral particle and it has been able to clearly distinguish 
between the inner and outer tegument which was previously hard to achieve 
(Laine et al., 2015). One of the main aspects of the herpes life cycle that is 
under debate is the site of secondary envelopment (Owen et al., 2015) and 
using a combination of high temporal microscopy and super-resolution 
microscopy to visualise secondary envelopment and its location can provide 
strong evidence, therefore it is important continue perusing and dissecting the 
viral life cycle using super-resolution microscopy techniques.  
 
The findings from this thesis is also important for the microtubule motors field 
as it identifies a new cargo for kinesin-3 family member Kif13B. Historically, it 
was not straight forward to identify specific cargoes for individual kinesins due 
to the ‘cargo problem’ (Terada and Hirokawa, 2000). Yeast two hybrid assays 
and immunoprecipitation assays have been used to identify biochemical 
interactions between kinesins, cargo proteins and adaptor molecules. 
Although this approach allows the identification of the binding partners it is not 
possible to gain insight into these interactions in vivo where these may be 
regulated (Hirokawa and Noda, 2008). Another strategy is to use RNAi or 
induce dominant negative mutations to disrupt specific kinesin motors and 
then examine the phenotypic changes that have occurred to presumed cargo, 
this can lead to unintended nonspecific secondary effects (Hirokawa et al., 
2010). These approaches also don’t take in to account for the possibility that 
more than one kinesin could be responsible for transporting a particular cargo. 
The split kinesin assay is a great tool for both identifying possible transporters 
of cargo and helps address the ‘cargo problem’ (Jenkins et al., 2012)  
Therefore, by employing the split kinesin assay along with RNAi depletion we 
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show that it is possible to identify which molecular motors are responsible for 
transporting cargo, including viral particles. 
 
Establishing that microtubules and Kif13B are important and required for 
efficient MDV spread has a lot of potential as a target for therapeutic drug 
treatment. With further research the importance of Kif13B during the 
development of poultry can be illuminated and potentially be targeted 
therapeutically. As there is currently no treatment for MDV infected poultry 
(Boodhoo et al., 2016) this could be the first therapeutic target to inhibit MDV 
viral spread in flocks. The current vaccines used do not stop the spread of 
MDV in flock and only stop the emergence of server symptoms like 
immunosuppression, oncogenic disease and neuropathy before slaughter 
(Nair, 2005). Potentially targeting Kif13B could inhibit or slow down the spread 
of wild type MDV in flocks. Targeting Kif13B has the potential to have side 
effects as targeting kinesin spindle proteins with chemotherapy drugs is 
associated with neurotoxicity in humans (Huszar et al., 2009) and a similar 
severe side effect could exist if Kif13B is targeted in poultry. The combined 
use of current vaccination strategies with possible Kif13B targeting could lead 
to the possible eradication of MDV in poultry farms.        
 
Based on our findings that dynein and kinesin-3 transport MDV viral particles 
and on literature that suggests certain viral proteins facilitate these 
interactions, two modes of MDV viral particle transport can be suggested 
during egress (Fig 6.1). The first is that nucleocapsids are transported by 
dynein and kinesin-3 via UL36 and US11 in a bi-directional manner, possibly 
to reach the secondary envelopment site. The second is that fully enveloped 
MDV particles are transported to the cell cortex via kinesin-3 and US9 








Figure 6.1: Possible models on how MDV viral particles are transported 
Dynein could be recruited to nucleocapsids via dynactin and MDV encoded tegument protein 
UL36. Kinesin-3 could be recruited to nucleocapsids in the cytoplasm via US11 tegument 
protein. The two motor proteins would then transport nucleocapsid to secondary envelopment 
site using bi-directional transport. Viral capsids that have under gone secondary envelopment 
could be transported to the cell cortex using kinesin-3s and US9 protein interactions. 
 
 
Our findings that actin filaments are essential for viral spread are in line with 
data reported previously (Richerioux et al., 2012, Schumacher et al., 2005). 
The Rho-ROCK and Rac-PAK signalling pathways that are involved in 
modulating F-actin have also been suggested to be essential for MDV viral 
spread. Efficient MDV spread is thought to require ROCK signalling and 
myosin II activity (Richerioux et al., 2012). The exact mechanisms to how 
these are important are yet to be confirmed. This study suggests that MDV 
viral spread requires both actin and microtubules for efficient viral spread. At 
which stage of the life cycle these two cytoskeletal elements come together to 
facilitate viral spread remains unknown. 
 
It has also been shown that HSV-1 viral glycoproteins are enriched at specific 
sites on the host membrane with the aid of the viral glycoprotein gE to direct 
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them (Mingo et al., 2012). At these sites, actin is slightly depleted, and this 
was determined to be required for trafficking viral components to the egress 
locations on the host membrane. It was previously hypothesised that viral 
particles are released near these egress sites and then trafficked to the egress 
site using actin surfing. Actin is also crucial for maintaining the egress site 
structurally and disrupting actin results in dispersing the glycoprotein 
concentrations (Mingo et al., 2012). Actin is required for egress site 
maintenance and viral particle actin surfing at the cell cortex (Roberts and 
Baines, 2011). Microtubules grow towards the cell cortex and viral particles 
are transported along them. Microtubules could be important for delivering 
viral particles to the cell cortex.  
 
 
6.1: Future Work 
 
The findings that microtubules are indispensable for MDV viral spread raises 
further questions. In this study we only looked at microtubules as a form of 
transport for MDV viral particles, it is possible that microtubules could also be 
important for other aspects of the MDV live cycle. Next steps would be to see 
if MDV infection results in any changes to microtubule dynamics in infected 
cells and if so, how microtubule dynamics is regulated.  
 
The identification and confirmation that MDV infection in CEF cells results in 
cellular shape changes is an important one and requires further study. Using 
3D culture systems, it would be interesting to study MDV spread. During a 
plaque assay the spread of MDV can be followed using fluorescence and the 
same approach can be taken in a 3D environment. This could be achieved by 
using CEF derived organoids and then infecting with fluorescent virus to follow 
its spread. LLSM would need to be employed in order to resolve individually 
infected cells in the organoid and follow them to visualise how infection is 





To further confirm that MDV viral capsids are transported by molecular motors 
co-localisation assays can be performed in infected cells, using a small 
fluorescent tag to visualise a molecular motor and viral particles could provide 
the final confirmation of direct interaction and transport of viral capsids by 
molecular motors ex vivo. As we have hypothesised the adaptor proteins 
(possibly viral US9, US11 and, UL36 proteins) that can possibly link the viral 
particle with the molecular can also be labelled fluorescently and using a multi 
camera system all elements can be imaged in high spatial and temporal 
resolution. Even further these complexes can also be reconstituted in vitro and 
visualised using TIRF microscopy. Finally, the molecular structure of the whole 
complex together with the viral particle, molecular motor and adaptor protein 
can be resolved.      
 
Finally, the potential of targeting Kif13B was a therapeutic target needs to be 
explored, this can be achieved by first identifying a compound that will reduce 
or completely inhibit Kif13B activity. This can be achieved by a large-scale 
inhibitory compound screen. Once compounds that inhibit Kif13B activity are 
identified then small-scale trials can be carried out in MDV permissive poultry. 
The rate of spread between small flocks of chicken can be determined and 
possibly a combination effect with modern vaccination strategies and Kif13B 













6.2: Conclusions  
 
This study provides the first evidence that MDV infection is associated with 
microtubules, both for intracellular transport and cell-to-cell spread. The 
dynamic microtubules are important for cell shape changes induced during 
MDV infection. The importance of actin has also been reemphasized, although 
the processes actin is involved in during the viral life cycle have not been 
investigated here. Using state-of-the-art approaches like SRRF, MDV viral 
particles were shown to be bound and directionally transported along 
microtubules, placing microtubules in the centre of intracellular MDV viral 
particle transport. This study has also identified two microtubule-associated 
molecular motors that are involved in the directional transport of MDV viral 
particles on microtubules, cytoplasmic dynein and Kif13B. The findings from 
this study identify new components of the host machinery required for MDV 
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